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Bronchopulmonary dysplasia (BPD) is a pulmonary disease that effects infants born < 32 
weeks gestational age.  Despite improved survival among preterm infants, the incidence 
and severity of BPD has not improved, rather the features and severity of BPD have 
evolved (Abman et al., 2017). BPD is a disease that has significant impact on the 
outcomes of preterm infants, including poor pulmonary and neurodevelopmental 
outcomes (Abman et al., 2017). Since its identification in 1967, and many iterations to its 
defining criteria, healthcare practitioners are unable to accurately predict infants’ risk of 
developing BPD. Further, there is significant family, social, and economic impacts from 
BPD. This dissertation research examined risk factors for BPD, as identified in a mid-
range theory developed from a systematic review of the literature. This mid-range theory 
is framed using the Neuman Systems Model (NSM) (2011). The research utilized a 
secondary analysis of data from a database including a cohort of infants born at < 32 
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weeks’ gestation (n=455) treated at Boston Children’s Hospital. Findings from this 
research demonstrated that multiple intrapersonal risk factors are associated with 
development of BPD and the grades of BPD severity including gestational age, birth 
weight, surfactant administration, necrotizing enterocolitis, infections, mechanical 
ventilation duration, and patent ductus arteriosus. This research adds to the current body 
of research by demonstrating specific risks associated with BPD.  Findings of this 
research could be used to identify maternal infant dyads that would benefit from early 
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Background and Significance 
Bronchopulmonary dysplasia (BPD; see Table 1) is a chronic lung disease unique 
to premature infants.  The disease was first identified in 1967 among a group of primarily 
preterm infants with the following characteristics: 1) diagnosed with respiratory distress 
syndrome (RDS, see Table 2); 2) exposed to oxygen and/or trauma related to mechanical 
ventilation; and 3) demonstrated evidence of persistent pulmonary disease at 28 days of 
life (Northway, Rosan, & Portar, 1967).  The initial diagnostic criteria for BPD included 
persistent oxygen requirement and abnormal respiratory symptoms until ≥ 28 -30 days of 
age, chest radiographic (CXR) findings including heterogeneous aeration, and (when 
available) evidence of pathology throughout the airway and lungs on postmortem 
examination (Northway et al., 1967).  Among the 32 infants in the first observational 
cohort the mean gestational age was ≥ 32 weeks’ gestation.  For those diagnosed with 
BPD in this cohort, the mortality rate was significant as 19 of the 32 infants did not 
survive (Northway et al., 1967).  
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There were significant improvements in the care of preterm infants since 1967. 
The improvements that had major impacts on the pulmonary health for preterm infants 
included antenatal steroids, postnatal surfactant administration, and gentle ventilation 
techniques. These will be discussed further in this paragraph. In the 1970’s, 
administration of antenatal steroids to mothers experiencing preterm labor was examined 
as it was hypothesized to reduce the incidence of RDS by releasing endogenous 
surfactant facilitating lung maturity, (Liggins & Howie, 1972).  During the trial in 1972 
(Liggins & Howie, 1972), infants whose mothers received antenatal steroids had 
significantly less RDS than those in the control group. Since the 1970’s, antenatal steroid 
administration for mothers in preterm labor is standard of care. Surfactant, a lipoprotein, 
increases in production in the final trimester of pregnancy and works to reduce 
pulmonary surface tension allowing for improved gas exchange. Typically, present in 
adequate amounts in full term infants, surfactant is deficient in preterm infants. This 
deficiency increases the risk for RDS (Halliday, 2008). Exogenous surfactant (see Table 
2) trials during the mid-to-late 1980’s demonstrated evidence that administration of 
surfactant during the first hours to days of life decreased the incidence of RDS and 
improved the survivability of preterm infants.  The United States Food & Drug 
Administration (FDA) approved the use of exogenous surfactant for the treatment of RDS 
in 1990 (NORD, 2004).  Following approval of surfactant, gentle ventilation techniques 
became routine, leading to less pressure-induced lung damage (Ehrenkranz et al., 2005; 
Jobe & Bancalari, 2001).  Yet, despite these interventions and improvements in the care 
of premature infants the incidence of BPD did not decrease.  While more infants survived 
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at younger gestational ages, improved survival led to a new, more complex form of BPD 
termed “new BPD” (Abman et al., 2017).   
The initial hallmark of BPD was heterogeneous lung expansion, demonstrated on 
CXR and consistent with surfactant deficiency (Northway et al., 1967).  Findings 
associated with the “new BPD” are more complicated and hallmarked by arrested lung 
development (Jobe & Bancalari, 2001).  To account for the changing population of 
preterm infants and the evolving pathology of BPD, the diagnostic criteria created in 
1967 and edited minimally through the subsequent years needed to be adapted.  The 
accepted criteria for grading BPD, still used today, was decided upon at a workshop 
attended by the members of the National Institute of Child Health and Human 
Development (NICHD), the National Heart, Lung, and Blood Institute (NHLBI), and the 
Office of Rare Diseases (ORD) in 2000.  These governing institutes/offices determined 
time points and respiratory support requirements demarcating diagnostic criteria for the 
grading of BPD (see Table 1). The diagnosis of BPD is made at 36 weeks’ postmenstrual 
age ([PMA] see Table 2) and is based on the need for oxygen delivered by a nasal 
cannula, non-invasive ventilation, or invasive ventilation at 28 days, as originally 
proposed by Shennan, Dunn, Ohlsson, Lennox, & Hoskins (1988). The new criteria 
proposed in 2000 added grading (i.e., mild, moderate, and severe BPD [see Table 1]) 
(Jobe & Bancalari, 2001) to account for the differing severity in BPD presentation and 
symptoms. The risks, costs, and outcomes for infants becomes more complicated as BPD 
severity increases.  
These new diagnostic criteria were validated in a research study examining the 
outcomes of 4866 infants born at < 32 weeks’ gestation.  When this cohort of preterm 
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infants was assessed between 18-22 months in follow-up clinics, the new BPD criteria 
was shown to be effective at identifying infants with abnormal pulmonary symptoms at 
28 days and 36 weeks’ PMA.  Further, this criterion was effective at identifying those 
infants with a higher risk for pulmonary and neurodevelopmental sequelae up to their 18-
22-month assessment in follow up clinic (Ehrenkranz et al., 2005).   
  There are recognized risk factors that are related to the development of BPD, 
especially severe forms of BPD.  The most significant risk factor is preterm birth in that 
there is an inverse relationship between gestational age at birth and the incidence of BPD.  
Strong associations for the development of BPD include male sex and duration of 
mechanical ventilation (Abman et al., 2017).  Additionally, certain postnatal conditions 
are associated with an increased risk of developing BPD (i.e., patent ductus arteriosus, 
sepsis, and necrotizing enterocolitis requiring surgery) [see Table 2] (Abman et al., 
2017).  Other proposed risks, some controversial, include race/ethnicity and 
chorioamnionitis, an intrauterine inflammatory and infectious process.  Laughon et al. 
(2011) developed a tool to evaluate the risk of BPD development among preterm infants. 
This tool employs some of the risks found in the literature. However, with continual 
evolution of the preterm infant population, reevaluation of risk must be conducted.  
Infants born at < 32 weeks’ gestation represent only 1.6% of the total births in the 
United States (Martin, Hamilton, Osterman, Driscoll, & Matthews, 2017).  BPD is a rare 
disease compared to other childhood illnesses but is one of the most common morbidities 
among infants born at < 32 weeks’ gestation (Abman et al., 2017).  The clinical course of 
infants with BPD is complicated by multiple comorbidities. These morbidities include 
neurodevelopmental impairment, extrauterine growth restriction (EUGR), pulmonary 
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hypertension, gastroesophageal reflux, feeding issues, retinopathy of prematurity, and 
systemic hypertension (Abman et al., 2017; Glass et al., 2015; Gou, Yang, & Xiao, 2018) 
(see Table 2). These complications become worse as BPD severity increases. As a result 
of the morbidities this multisystem disease is considered a significant challenge for 
healthcare providers as well as the families.  
Despite identification of BPD more than 50 years ago as well as multiple 
iterations of the diagnostic criteria, there has been no improvement in the incidence, 
morbidity, or mortality rates since the adoption of the criteria in 2001 (Abman et al., 
2017).  There are several grades of BPD, each with associated prevalence in the 
population of infants born at < 32 weeks’ gestation: no BPD (23.1%), mild BPD (30.3%), 
moderate BPD (30.2%), and severe BPD (16.4%) (Ehrenkranz et al., 2005).  Despite 
reduction efforts, the incidence and severity of BPD has not changed since 2005 (Abman 
et al., 2017). One conservative estimate is that 2,000 infants and children require home 
ventilation in the United States due to BPD (Abman et al., 2017).  Mortality related to 
BPD is similarly not well understood, as cause of death for those infants could also be 
attributed to prematurity, respiratory failure, and comorbidities such as pulmonary 
hypertension. 
The economic impact of BPD is unknown but is considered one of the most 
expensive morbidities of prematurity (Johnson, Patel, Jegier, Engstrom, & Meier, 2013; 
Lapcharoensap, Lee, Nyberg, & Dukhovny, 2018). Another significant barrier to cost 
estimates is that most reports only evaluate the cost of neonatal intensive care 
hospitalization.  BPD, especially more severe forms of BPD, has many additional costs 
beyond the NICU such as the cost of specialty services, tracheostomy placement, in-
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patient rehabilitation, home care, durable medical equipment, home medication, 
outpatient providers, and rehospitalization (Abman et al., 2017).  These costs incurred 
post NICU hospitalization are not included in economic estimates. Further, chronic 
morbidities such as neurodevelopmental impairment increases lifetime healthcare costs 
but is not included (Abman et al., 2017; Lapcharoensap et al., 2018).   
One estimate for the cost of BPD is an additional average cost of $31,565 above 
the costs incurred during neonatal intensive hospitalization.  This cost increased as birth 
weight decreased (cost ranging $19,970 for larger preterm infants to $43,312 for smaller 
infants; Johnson et al., 2013).  A more encompassing estimation of costs included care 
during NICU hospitalization and associated morbidities, cumulating to a median cost of 
$102,000 for infants with BPD (Lapcharoensap et al., 2018).  In contrast, the cost of 
hospitalization for uncomplicated full-term newborns is $500, and $36,800 for an 
uncomplicated infant born at < 28 weeks’ gestation (Lapcharoensap et al., 2018).  These 
cost estimates do not account for lost productivity or wages of either caregivers or those 
with BPD.  Reports on the societal impact for BPD are sparce, but significant.  From a 
psychologic perspective, mothers of infants with BPD are more likely to have significant 
postpartum depression than those without BPD (Brady, Zhang, Kirpalani, & DeMauro, 
2019; Moura et al., 2017). BPD is a diagnosis that poses great challenges to the patients 
and their families from a psychological and economic perspective.  
The care for preterm infants has changed significantly and so have the limits of 
viability, thus younger preterm infants are surviving.  BPD is no longer a sequalae of 
surfactant deficiency. The “new BPD” is characterized by an arrest in lung development, 
simplified alveoli, and reduced pulmonary microvasculature (Abman et al., 2017).  
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Societal and economic impact is significant with BPD, especially as the severity of BPD 
increases (Abman et al., 2017; Johnson, Patel, Jegier, Engstrom, & Meier, 2013; 
Lapcharoensap, Lee, Nyberg, & Dukhovny, 2018).  While BPD is a rare outcome 
considering all other childhood illnesses, it has significant health, economic, and societal 
costs. The purpose of this study is to examine the risk factors for BPD as identified in   
the developed mid-range theory. The variables in this mid-range theory can be used to 
identify infants at risk for BPD. Further, understanding the stressors and identifying 
infants at risk may lead to risk reduction and treatment strategies that can be targeted to 





















Impact of BPD on Families and Society 
Less than two percent of infants in the United States are born at < 32 weeks’ 
gestation (Martin et al., 2017).  While BPD is a rare disease among all children, it is a 
common diagnosis for infants born at < 32 weeks (Abman et al., 2017). Of infants born at 
< 32 weeks’ gestation 76.9% are diagnosed with BPD (Ehrenkranz et al., 2005).   
A diagnosis of BPD increases the cost of neonatal intensive care hospitalization 
by an average of $31,565, for each infant.  When NICU hospitalization and associated 
morbidities were combined, the median hospital costs for infants with BPD were 
$102,000 (Lapcharoensap et al., 2018).  Lost productivity and wages for caregivers are 
not included in these estimates.  There are also scant although important reports on the 
societal impact of BPD. From a psychologic perspective, mothers of infants with BPD 
are more likely to have higher rates of postpartum depression and poorer perceived 
quality of life than mothers whose infants do not have BPD (Brady, Zhang, Kirpalani, & 





 Kingdon (2011) described the convergence of three streams (problem, politics, 
and policy) as the means to address a political agenda.  Prior to the 1960’s the morbidity 
and mortality of preterm infants was staggering.  Health care professionals and 
researchers were working to improve the survivability of preterm infants. Advancing the 
care of preterm infants became a national priority with the death of President John F. 
Kennedy’s son who died as a result of his premature birth in 1963 (Altman, 2013).  
Patrick Kennedy was born prematurely at almost 35 weeks’ gestation and suffered from 
RDS. RDS is caused by a lack of surfactant in the lungs, which leads to reduced 
pulmonary surface tension and causes significant difficulty with ventilation and 
oxygenation (Altman, 2013; Halliday, 2008). In 1963 only supportive care could be 
offered for RDS.  Unfortunately, he died at two days-of-life.   
After Patrick’s death the political climate was right to advance the political and 
research agenda to improve the care for preterm infants, by increasing National Institutes 
of Health funding (Halliday, 2008). One of the most important advances was the 
administration of exogenous surfactant to treat RDS (Halliday, 2008).  Clinical trials 
were conducted in the 1980s and surfactant was approved by the FDA in 1990 for the 
treatment of RDS (NORD, 2004).  Administering surfactant to preterm infants is now 
standard of care. Were Patrick Kennedy to have been born today, administration of 
exogenous surfactant would have near guaranteed his survival.  The political climate of 
the early 1960’s was an ideal environment for this convergence to change the policies and 
practices involved in the care of preterm infants. Legislators and healthcare personnel 
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were motivated by prematurity and cognitive impairment (problems), which led to 
political action and ultimately a change in health care policy.   
Conceptual Framework 
The conceptual model guiding this dissertation is the Neuman Systems Model 
(NSM) (2011), a holistic systems approach. The aim of NSM is to reduce stress factors 
and adverse conditions which either affect or could affect optimal functioning in a client 
population (Fawcett & Neuman, 2011). The stressors that affect a given client population 
can be viewed as extrapersonal (occurring outside the individual), interpersonal 
(occurring between one or more individuals), and intrapersonal (occurring within the 
individual) (Fawcett & Neuman, 2011). The goal of the individual is to achieve 
homeostasis to adequately cope with the stressors and/or regain their optimal state of 
health following a reaction to a stressor. In regard to the development of BPD, many 
stressors have been identified in the literature.  
A systematic review of the literature was conducted to identify the most 
influential risk factors that leads to the development of BPD.  Employing the NSM, these 
factors were categorized by extrapersonal, interpersonal, and intrapersonal stressors.  
Extrapersonal stressors are represented by maternal race/ethnicity and genetics, including 
the sex of the neonate.  In the literature the role of maternal race/ethnicity in BPD 
development was conflicting and found to be both a risk for BPD and a protective factor 
against BPD development (Janevic et al., 2018; Lapcharoensap et al., 2015). The 
interpersonal stressors represented prenatal risks of inflammation, infection, and maternal 
vascular underperfusion (e.g., chorioamnionitis).  Finally, intrapersonal stressors are 
11 
 
represented by risk within the premature infant that requires intervention(s) and care in 
the NICU (e.g., surfactant administration).  
Chronic exposure to racism experienced by Black Americans is also known as an 
allostatic load (Alhusen, Bower, Epstein, & Sharps, 2016; Bediako, BeLue, & Hillemeier, 
2015; Scott, Britton, & McLemore, 2019).  This allostatic load can manifest as 
physiologic alterations. Racism and allostatic load affect each of the stressors in the 
NSM.  This research will test a mid-range theory developed from the systematic review 
focusing on the extrapersonal, interpersonal, and intrapersonal stressors contributing to 
the development of BPD among infants born at < 32 weeks’ gestational age. The review 
of studies that focused on risk factors in the development of BPD showed an 
interrelationship between the three stressors of the NSM (see Figure 1).  
The confluence of extrapersonal and interpersonal risks can culminate into 
premature delivery, leading to a decrease in the number of alveoli, and reduction in 
pulmonary microvascular development (Abman et al., 2017).  Preterm birth introduces 
postnatal risks, thus continuing lung development arrest, and solidifying the pathway to 
BPD.  While intrapersonal risks do not initiate the process of alveolar simplification or 
pulmonary microvascular development reduction, they continue the pathogenesis towards 
the development of BPD through premature delivery of the infant. Inflammation, 
infection, poor growth, and associated adverse events all contribute to the compounded 
risk for BPD (Abman et al., 2017).  
 Infants that have insults or risks in each of the stressors in this midrange theory 
are hypothesized to be at highest risk for BPD development when compared to preterm 
infants of the same age without similar risks.  Following testing of this midrange theory, 
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it may be used to identify infants at risk and lead to risk reduction and treatment 
strategies that can be targeted towards these high-risk infants to prevent BPD. The 
following discussion describes in more detail all the stressors within the mid-range theory 
that are predicted to increase the likelihood of the pathogenesis of BPD. The NSM will be 
employed to describe and organize the stressors. 
The normal line of defense represents the usual health state of the client system 
(i.e. patient) (Fawcett & Neuman, 2011). Testing this mid-range theory of BPD risk could 
lead to the development of interventions that could act as the flexible line of defense to 
decrease the risk of BPD. Infants with BPD have health ramifications that worsen as BPD 
severity increases. Some ramifications of more severe BPD include pulmonary 
hypertension, poor growth, and neurodevelopmental impairment (Abman et al., 2017). 
Therefore, grading is used to indicate the presence and types of BPD.  
Extrapersonal Stressors 
 Extrapersonal stressors in the NSM are distal to the client (Fawcett & Neuman, 
2011). In the mid-range theory, these stressors are represented by preconception factors 
and include genetic/epigenetic factors including sex of fetus, maternal sociodemographic 
factors, and allostatic load.  
Sex 
Male sex has been associated with BPD since its first identification (Northway et 
al., 1967).  Data demonstrates diminished biosynthesis of androgen, a higher density of 
androgen receptors, a decreased metabolism of androgen, and decreased degradation of 
estrogen among male infants that developed BPD (Lal et al., 2018a).  Furthermore, the 
male fetus has a delayed surfactant production secondary to these sex/hormonal based 
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differences, leading to increased resistance in the alveoli and control in the budding of the 
bronchioles during early fetal development (Shim, Cho, Kong, & Park, 2017). This 
knowledge provides insight into a sex-based hormonal mechanism increasing the risk for 
BPD among male infants.   
Genetic/Epigenetic Risks 
Genome-wide association studies (GWAS) and deoxyribonucleic acid (DNA) 
analysis have been used to identify genetic markers and/or variants that are associated 
with BPD (Ambalavanan et al., 2015).  To date there have been no conclusive gene(s) 
identified that are associated with BPD. Further, genetic/epigenetic risk evaluations are 
not consistently performed for all infants with BPD. Due to lack of standardization in the 
incorporation of genetic/epigenetic evaluation in the routine care for infants with BPD, 
genetic/epigenetic variables were not measured in this study and will not be further 
discussed.  
Race/Ethnicity and Preterm Birth 
Preterm birth is the most significant risk factor for BPD.  While the overall 
incidence of preterm birth in the United States (U.S.) is 10%, the incidence of preterm 
birth is 13% for Black Americans as compared to 9% for White Americans (CDC, 2016).  
The etiology of this significant health disparity may be due to a complex interaction of: 
1) racism and allostatic load and 2) maternal access/utilization/quality of health care 
concerns (Alhusen, Bower, Epstein, & Sharps, 2016; Bediako, BeLue, & Hillemeier, 
2015; Scott, Britton, & McLemore, 2019).  Given the complexity of these issues each 
will be discussed separately.  
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Racism and Allostatic Load. Racism is defined as “unequal treatment stemming 
from skin color or other individual characteristics” (Alhusen et al., 2016, p. 2).  Allostatic 
load is the effect(s) of chronic exposure to racism and the associated physiologic 
alterations, including impaired immune function and increased inflammation (Giurgescu 
et al., 2016; Olson et al., 2015).  Biomarkers of allostatic load include cortisol, cytokines, 
interleukin-6, and C-reactive protein; each of these are inflammatory mediators (Olson et 
al., 2015).  Among pregnant women, allostatic load is evidenced by an increase in 
preterm birth, pre-eclampsia, fetal growth restriction, inflammatory disease, and more 
(Alhusen et al., 2016; Giurgescu et al., 2016; Olson et al., 2015). Allostatic load has the 
capacity to perpetuate the significant health disparity experienced by Black Americans in 
immediate and subsequent generations through alterations in the inflammatory cascade 
(Olson et al., 2015).     
Prematurity is the most consistent risk factor for BPD. The incidence of 
prematurity is higher among Black infants (CDC, 2016). However, the association of 
race/ethnicity and risk for BPD is inconsistent in the literature; there is literature 
supporting the role of race/ethnicity in BPD development as protective in Black neonates 
(Lapcharoensap et al., 2015), as well as  a potential risk for BPD development (Janevic et 
al., 2018).  The association between race/ethnicity, and BPD is complex and deserves 
further exploration.   
Access/Utilization/Quality of Health Care. Access to health care is a complex 
process that ideally begins with preconception care.  This is in relationship to the fetus’ 
environment during pregnancy.  While approximately 50% of births and care up to 60 
days following birth are covered by public insurance in the United States, comprehensive 
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preconception care is not available to all pregnant women (Scott, Britton, & McLemore, 
2019).  Black women are more likely to be uninsured, thus are least likely to have access 
to preconception care. This makes them more likely to have ineffective management of 
any health conditions, should they arise, either during the pre-pregnancy or during 
pregnancy (Scott et al., 2019).  Also, a result of their lack of insurance and access to 
healthcare they may be more likely to have under or undiagnosed chronic conditions for 
which they will not have received health education and/or treatment.   
The relationship between early prenatal care and improved obstetric and neonatal 
outcomes, including reduction of preterm birth, have been well established (Daniels, Noe, 
& Mayberry, 2006).  However, many barriers still exist to receiving prenatal care 
including lack of: 1) health insurance, 2) availability of providers, 3) time availability for 
the mothers to attend lengthy appointments, 4) transportation to the appointments, and 5) 
availability for the long wait times in clinics.  These factors have all been reported as 
barriers to prenatal care especially for Black women (Scott et al., 2019; McLemore et al, 
2018). Twenty-two percent of Black mothers enter prenatal care late, whereas 15% of 
White mothers have late entry (Bediako et al., 2015; Edmonds, Mogul, & Sheen, 2015; 
U.S. Department of Health and Human Services, 2013).   
Once able to access prenatal care, the four other factors that decrease prenatal 
care, the availability of providers, transportation to prenatal care appointments, length of 
wait times, and insurance status, continue to impact prenatal care.  Black mothers cited 
many barriers to accessing and maintaining prenatal care including; 1) insurance status; 
2) understanding the Medicaid enrollment and eligibility; 3) lack of social support to 
attend prenatal care appointments; 4) transportation to appointments; 5) long wait times 
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in clinics; 6) ambivalence to pregnancy; 7) and having an unwanted pregnancy without 
access to providers to discuss health care options (Daniels, 2006; Edmonds et al., 2015).   
Issues within the provider and women relationship continue to impact prenatal 
care for Black mothers.  These issues include the lack of personal connection to their 
provider, lack of continuity of care with providers, and disrespectful actions by health 
care personnel.  For example, Black mothers with public insurance perceived that clinic 
staff were less responsive and respectful of them as compared to mothers with private 
insurance (Salm, Mazul, Ngui, Bridgewater, & Harley, 2013).  Public insurance was 
perceived as a barrier to quality health care by impacting mothers’ options for hospitals 
and choice of providers (Salm et al., 2013; Scott et al., 2019).  Women who had public 
insurance reported they felt they were viewed as less important by their providers and 
subsequently these impressions by providers was shown to lead to substandard care 
(Salm et al., 2013; Scott et al., 2019). Also, another research study found that Black and 
Hispanic mothers were more likely to give birth at poorer performing hospitals.  Infants 
born at these poorer performing hospitals had higher morbidity and mortality rates as 
compared to infants born at higher performing hospitals (Howell et al., 2018).  
Less access to health care does not only impact the number of appointments that 
Black mothers attend but also the prenatal education they receive due to a decrease in 
provider encounters. Many behavioral factors have been well established as causing an 
elevated risk for preterm birth especially in Black women.  These behavioral factors 
include diabetes (Cabacungan, Ngui, & McGinley, 2012; Scott et al., 2019), hypertension 
(Cabacungan et al., 2012; Scott et al., 2019), sexually transmitted infections (STIs) 
(Cabacungan et al., 2012) pre-pregnancy obesity (Bediako et al., 2015), smoking 
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(Bediako et al., 2015), and inappropriate weight gain during pregnancy (Cabacungan et 
al., 2012).  These conditions are impacted by the number of prenatal appointments and 
amount of education received. Access, utilization, and quality of health care are 
important contributing factors in preterm birth and potentially BPD development. 
However, these details are not available in the database that will be used for this research 
and they are not available in the Boston Children’s Hospital medical records. Therefore, 
these data were not included in this research. 
Interpersonal Stressors  
 Interpersonal stressors occur outside but proximal to the client (Fawcett & 
Neuman, 2011). Interpersonal stressors in this study’s mid-range theory include prenatal 
inflammation, prenatal infection, and maternal vascular underperfusion.  
Prenatal Inflammation 
A systematic review of the literature identified several inflammatory biomarkers 
markers associated with the development of BPD. KL-6 is a high molecular weight 
mucinous glycoprotein expressed by alveolar type II cells and bronchiolar epithelial cells 
and is elevated in the setting of damage to the pulmonary epithelium and interstitium 
(Kim et al., 2008; Ogihara et al., 2006).  Interleukin-8 (IL-8) is another inflammatory 
biomarker identified from the systematic review.  IL-8 is a glycoprotein that regulates the 
innate immune response, the adaptive immune response, and the growth/differentiation of 
hematopoietic cells (Rocha et al., 2012).  Biomarkers for fetal inflammation have been 
associated with chorioamnionitis, a bacterial infection of the fetal membranes that also 
leads to inflammatory changes present in the mother and the fetus.  Biomarkers are not 
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routinely collected in the NICU, so they are not routinely reported in the database or the 
Boston Children’s medical record and will not be a focus of this research.  
Clinical methods to detect histologic chorioamnionitis were consistently 
performed according to the method outlined by Redline (2006), where a pathologic 
evaluation is completed to diagnose both maternal and fetal acute and chronic 
inflammation (Mestan et al., 2014). More specifically, for acute maternal inflammation, a 
neutrophil infiltration of the chorion, amnion, and at its most severe, necrotizing 
chorioamnionitis is evident (Redline, 2006).  Chronic inflammation involves neutrophilic 
infiltration of the chorionic villi, intervillious space, and/or basal plate; this demonstrates 
inflammation with placental involvement (Redline, 2006).  These biomarkers associated 
with chorioamnionitis are associated with damage to the lungs, immune system, and even 
growth/differentiation of hematopoietic cells (Kim et al., 2008; Ogihara et al., 2006; 
Rocha et al., 2012). 
Prenatal Infection  
Infection initiates an inflammatory process. Like antenatal inflammation, 
antenatal infection is a risk for BPD because of the resulting changes in lung surfactant 
composition, potentiation of the alveolar and vascular simplification, and contribution to 
the imbalance between pro and anti-angiogenesis (Thekkeveedu, Guaman, & Shivanna, 
2017).  Biomarkers for infection were represented by positive bacterial culture results and 
were associated with IL-8 (like inflammation). One bacterial organism associated with 
BPD is ureaplasma (Inatomi et al., 2012).  In the literature, antenatal infection is 
clinically represented by chorioamnionitis. Histologic chorioamnionitis was described 
above.  Clinical chorioamnionitis (CC) is diagnosed by one of two methods, either by 
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placental pathology or by maternal clinical signs and symptoms indicative of 
chorioamnionitis (American College of Obstetricians and Gynecologists, 2017; Arayici et 
al., 2014; Ballard et al., 2016; Kibel et al., 2016; Lee et al., 2011; Mestan et al., 2014; 
Redline, 2006; Solimon et al., 2017). Both diagnostic methods necessitate presence of a 
maternal fever (Arayici et al., 2014; Ballard et al., 2016; Kibel et al., 2016; Lee et al., 
2011; Solimon et al., 2017).  Depending on the source, either one or more of the 
following signs must be present for CC to be diagnosed: maternal tachycardia, fetal 
tachycardia, uterine tenderness, malodorous amniotic fluid, leukocytosis, and/or elevated 
C-reactive protein.  The criteria from the American College of Obstetricians and 
Gynecologists (ACOG) uses the more conservative approach when diagnosing CC; 
maternal fever and at least one other clinical sign (Ballard et al., 2016; ACOG, 2017).  
Criteria for diagnosing histologic chorioamnionitis (HC) is based on a pathological exam 
of the placenta. When diagnosing HC there must be infiltration of neutrophils into the 
amniotic membranes, the umbilical cord, or the chorionic plate (Arayici et al., 2014; 
Durrmeyer et al., 2012; Lee et al., 2011; Redline, 2006; Solimon et al., 2017; Yum et al., 
2018).  HC and CC are diagnoses consistent with infection. HC and/or CC is acceptable 
to use to diagnose chorioamnionitis in clinical practice.  
Maternal Vascular Underperfusion 
Maternal vascular underperfusion (MVU) is defined by pathological changes to 
the placenta that can cause fetal growth restriction and increase risk for BPD and BPD 
associated pulmonary hypertension (Mestan et al., 2014; Mestan et al., 2017).  The 
mechanism for BPD development among preterm infants whose mothers had 
hypertensive disorders is thought to be related to an imbalance of pro- and anti-
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angiogenic factors.  This disparity in angiogenic factors is believed to cause abnormal or 
insufficient vascular and alveolar pulmonary development (Dravet-Gounot et al., 2018).  
There are many biomarkers associated with MVU identified from a systematic 
review of literature.  Some of the biomarkers were the same as ones associated with 
inflammation and infection, such as KL-6 and cytokines.  Other factors were unique to 
MVU were either pro or antiangiogenic (i.e., endothelin-1, fibroblast growth factor-10, 
and tumor necrosis factor) (Baumann et al., 2015; Janer, Andersson, Haglud, Karikoski, 
& Lassus, 2008; Kim & Kim, 2014; Kim et al., 2008; Kim, Shin, Kim, & Kim, 2018; 
Mohamed et al., 2014; Ogihara et al., 2006; Rocha et al., 2012.  
MVU can be diagnosed clinically and/or pathologically. Clinically, MVU 
presents as maternal hypertensive disorders such as gestational hypertension, 
preeclampsia, HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet 
count), and/or eclampsia [see Table 2] (ACOG, 2002; Solimon et al., 2017; Torchin et al., 
2016).  The criteria for diagnosing maternal hypertensive disorders was consistent across 
the literature and are the basis of the ACOG guidelines (ACOG, 2002).  Criteria for 
pathologic evaluation of MVU was also consistent across all the studies specifically, 
vasculopathy of the parietal and basal decidua. MVU is graded as either mild or severe, 
depending on the number of lesions visualized (Redline et al., 2004). Maternal 
hypertensive disorders (chronic hypertension, gestational hypertension, preeclampsia, 
HELLP syndrome) are the empiric indicator for MVU in this research.  
Fetal growth is associated with BPD thus birth weight is a critical measure to 
assess as it may be indicative of poor fetal growth (Charles et al., 2019). Further, fetal 
growth restriction (FGR) is associated with maternal vascular underperfusion, which is a 
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risk factor for BPD development.  Infants with FGR experience a higher incidence and 
severity of BPD.  FGR, small for gestational age, and intrauterine growth restriction are 
all synonymous in the literature and are defined as growth <10th percentile based on fetal 
growth curves (El Ayoubi et al., 2016; Nyp et al., 2015; Ozkan et al., 2012; Tsai et al., 
2015). FGR will be used as the empiric indicator for this research. 
Intrapersonal Stressors 
 These stressors are measured and/or occur postnatally within the premature infant. 
Infant characteristics include gestational age, birth weight, inflammation, infection, 
patent ductus arteriosus, and EUGR requiring interventions delivered in the NICU. These 
NICU interventions include doses of surfactant, number of transfusions of packed red 
blood cells, duration of mechanical ventilation.  
Infant Characteristics 
 Infant characteristics associated with BPD include demographics such as 
gestational age and birth weight, postnatal inflammation and infection, patent ductus 
arteriosus, and EUGR. 
Gestational Age. A hallmark of BPD is an arrest of lung development; the earlier 
the arrest, the less lung development has occurred at the time of birth. Further, the earlier 
the gestational age at birth, the earlier the exposure to oxygen and mechanical ventilation 
(Abman et al., 2017). This exposure to oxygen and mechanical ventilation injures 
vulnerable, underdeveloped lungs. Gestational age, measured in completed weeks of 
gestation, is inversely related to the incidence and severity of BPD and is multifactorial 
(Abman et al., 2017). This relationship is multifactorial. 
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The initial determination of gestational age commonly employed when 
confirming pregnancy, is based using either the date of the last menstrual period (LMP) 
and/or the estimate from a first trimester ultrasound (Binet et al., 2012; Dravet-Gounot et 
al., 2018; Mestan et al., 2014; Torchin et al., 2016; Tsai et al., 2015).  The Ballard exam 
is a a systematic physical examination to assess preterm infants’ gestational age. It was 
expanded in 1991 to include the assessment of gestational ages 20-44 weeks’ (Ballard et 
al., 1991; Ozkan et al., 2012). This exam is most accurate when conducted in the first 96 
hours of life and when compared with prenatal ultrasound, the New Ballard Score had a 
correlation of 0.97 and inter-rater reliability of 0.95 (Ballard et al., 1991). While the New 
Ballard is accurate, one limitation is that training is necessary to reliably complete the 
exam.  Additionally, the results of the Ballard exam can be affected by issues such as 
sedating medications used during labor, sepsis, and neuromuscular disorders (Ballard et 
al., 1991).  Clinically, the Ballard exam is useful to estimate gestational age when it is 
unknown, otherwise gestational age is most reliable when based on either LMP or 
ultrasound.  
Birth Weight.  According to the literature, infants born at lower birth weight 
have a higher risk for developing BPD.  Further, infants with the lowest birth weights not 
only have a higher risk for BPD, but of also developing more severe forms of BPD 
(Dravet-Guonot et al., 2018; Guo et al., 2015). This relationship between BPD and lower 
birth weight is in part due to the association between low birth weight and maternal 
vascular underperfusion, and the relationship with an imbalance between pro and anti-
angiogenic factors (Dravet-Guonot et al., 2018).  
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Fetal growth is a comprehensive and objective assessment of intrauterine growth. 
Fetal growth is estimated during pregnancy, and then finalized with birth weight. Poor 
fetal growth and low birth weight have many associated morbidities, including BPD (El 
Ayoubi et al., 2016; Nyp et al., 2015; Ozkan et al., 2012; Tsai et al., 2015).  Infants with 
fetal growth restriction (FGR) experience a higher incidence and severity of BPD.  FGR, 
small for gestational age (SGA), and intrauterine growth restriction (IUGR) are all 
defined as growth <10th percentile based on fetal growth curves. The Fenton Growth 
Chart (Fenton & Kim, 2013) is the most inclusive growth chart for preterm infants.  Data 
for the Fenton Growth curve was formulated through a systematic review and meta-
analysis from six developed countries among infants aged 22-36 weeks’ gestation. 
Unique to this growth curve was synchronization with the World Health Organization 
(WHO) Growth Standard, which extended the growth chart through 50 weeks PMA.  The 
WHO Growth Standard is an international standard for measuring the growth of full term, 
breastfed infants, living in countries with adequate nutrition, and it is the standard for 
growth assessment in the United States (The Centers for Disease Control and Prevention 
[CDC], 2010).  Syncing the intrauterine growth curves with the WHO growth standard 
allows healthcare professionals to continue to monitor the growth of preterm infants 
based on the growth of full-term infants with optimal nutrition (CDC, 2010).  Based on 
these details, the Fenton Growth Curve is the most comprehensive tool of growth 
measurement. Infants with a birth weight of <10th percentile, per the Fenton Growth 
Chart, will be considered to have FGR for this research. 
Postnatal Inflammation. The systematic review of the literature identified many 
biomarkers associated with inflammation due to oxygen, oxidative stress, and exposure to 
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mechanical ventilation. For example, leukotriene E4 (LTE-4) is an inflammatory marker 
related to damage to the cell membrane in asthma (Joung et al., 2011), and oxidative 
stress was measured using 8-hydroxydeoxyguanosine (8-OHdG) (Joung et al., 2011).  
However, the most common reported biomarker was brain natriuretic peptide (BNP) or 
the inactive form of BNP, N-terminal-pro-BNP. BNP and N-terminal-pro-BNP measure 
the same physiologic process: measurement of ventricular stretch.  Both BNP and N-
terminal-pro-BNP are elevated in both BPD and BPD associated pulmonary hypertension 
due to hypoxia and chronic hypoxia and both are experienced by infants with BPD (Cuna 
et al., 2013; Cuna et al., 2014; Harris et al., 2018; Inoue et al., 2013; Kalra et al., 2014; 
Konig et al., 2016; Montgomery et al., 2016; & Rodriguez-Blanco et al., 2018). Finally, 
the association of inflammation, infection, and angiogenic factors was valuable to 
quantify. Neutrophil gelatinase-associated lipocalin (NGAL) was used to quantify the 
intersection of infection, inflammation, and angiogenic factors in sBPD development and 
found to be elevated in BPD (Capoluongo et al., 2008; Joung et al., 2011; Reicherzer et 
al., 2018; & Sarafidis et al., 2008).   
Given the evidence of an association with inflammation and BPD, postnatal 
exposure to sources that could lead to inflammation were identified. The postnatal 
exposure(s) leading to inflammation originate from several sources including exposure to 
oxygen, need for mechanical ventilation (Inatomi et al., 2012; Klevebro et al., 2019; 
Mailaparambil et al., 2010; Oh et al., 2005; Ohlin et al., 2015; Rutkowska et al., 2019; 
Yum et al., 2018), and diagnosis of necrotizing enterocolitis (NEC), an inflammatory 
bowel infection [see Table 2] (Cuna et al., 2013; Cuna et al., 2014; Harris et al., 2018; 
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Inoue et al., 2013; Kalra et al., 2014; Konig et al., 2016; Montgomery et al., 2016; & 
Rodriguez-Blanco et al., 2018).  
Premature lungs often lack the ability to adequately exchange gasses efficiently 
due to immature alveoli and lack of energy required to breathe. Therefore, mechanical 
ventilation is often required to assist premature infants with their work of breathing and 
gas exchange. However, there are side effects to mechanical ventilation including 
pressure and volume related trauma and oxygen toxicity. Each of these exposures incur a 
risk of inflammation (Abman et al., 2017; Laughon et al., 2011). When this inflammatory 
process is initiated there is disruption to alveolarization and vasculogenesis, which further 
interrupts adequate pulmonary growth (Mailaparambil et al., 2010). Oxygen exposure 
frequently changes during each day for a preterm infant in the NICU. Therefore, 
mechanical ventilation duration (total, non-invasive, and invasive) was the empirical 
indicator for this variable. 
NEC was defined using Bell’s Staging, the standardized assessment (Bell et al., 
1978).  NEC stage 2 includes: 1) perinatal stress, 2) signs of sepsis and gross 
gastrointestinal bleeding or abdominal distention, 3) abdominal radiograph demonstrating 
ileus, unchanging bowel loops, pneumatosis, and/or portal venous gas.  Bell’s Stage 3 
included all criteria from stage 2 and: 1) signs of septic shock or marked gastrointestinal 
hemorrhage, and 2) evidence of pneumoperitoneum on radiograph (Bell et al., 1978). 
When measuring NEC as a variable, the studies only included patients with NEC ≥ stage 
2 [see Table 2] (Bell et al., 1978).  The empirical indicator for NEC was ≥ stage 2 (Bell et 
al., 1978). Mechanical ventilation duration (total, non-invasive, and invasive) and a 
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diagnosis of NEC ≥ Bell’s stage 2 were the empirical indicators for postnatal 
inflammation. 
Postnatal Infection. Methods that were used to measure infection consistently 
employed the results of bacterial cultures obtained from sites of the neonate that should 
be sterile (i.e., blood, spinal fluid, tracheal aspirates, and urine). A positive culture in any 
of these sites was considered evidence of an infection (Ballard et al., 2016; Dravet-
Gounot et al., 2018; Durrmeyer et al., 2012; Guo et al., 2015; Klevebro et al., 2019; Lee 
et al., 2011; Ohlin et al., 2015; Solimon et al., 2017; Torchin et al., 2016). Clinical sepsis, 
where culture results were negative, but the patient demonstrated signs of an infection, is 
also a risk factor for sBPD (Hofer et al., 2013; Ohlin et al., 2015).  Measurement of 
clinical sepsis was consistent between studies and included negative bacterial cultures. 
Infants were assessed as having an infection when they demonstrated three or more of the 
following clinical signs: respiratory compromise, cardiocirculatory compromise, 
neurological compromise, poor physical color, prolonged capillary refill time, and either 
hypothermia or hyperthermia. Yet another method of measuring inflammation in the 
preterm neonate was with the diagnosis of NEC ≥ stage 2 (Bell et al., 1978).  When 
measuring NEC as a variable, the reviewed studies only included patients with NEC ≥ 
stage 2.  For this study, there were two empiric indicators for postnatal infection: NEC ≥ 
Bell’s stage 2 and/or positive blood, urine, spinal fluid, or tracheal aspirate cultures.  
Patent Ductus Arteriosus (PDA). PDA is a normal prenatal shunt that allows 
blood flow to bypass the fetal lungs (United States National Library of Medicine, 2020).  
In full term infants the PDA typically closes by 72 hours of life, but closure of the PDA is 
delayed among preterm infants. Time to PDA closure is inversely related to gestational 
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age; the delay is significantly longer among very preterm infants. Therefore, a PDA is not 
considered an unexpected structural heart defect in preterm infants.  
 PDA closure requiring treatment is also more common among preterm infants 
(Benitz, 2016). In the systematic review of the literature, diagnosis of a PDA was 
associated with developing BPD (Dravet-Gounot et al., 2018; Demirel et al., 2009; Guo 
et al., 2015; Rutkowska et al., 2019; Torchin et al., 2016).  Further, a PDA that required 
surgical closure was also associated with developing BPD (Durrmeyer et al., 2012; 
Mailaparambilel et al., 2010). PDA increases pulmonary pressure and the amount of fluid 
in the interstitium, which leads to pulmonary edema. This frequently leads to prolonged 
respiratory support or increased respiratory support needs. However, none of these 
identified risks play a causative role of BPD development.  Instead they may be markers 
for severity of the infant’s condition and the injury induced due to pulmonary edema 
(Clyman, 2013). PDA data was first classified as either present or not present (diagnosed 
by echocardiography). If an infant was diagnosed with a PDA, they would be further 
classified as either requiring no treatment or needing treatment to facilitate closure.  
Treatment for a PDA was either medical treatment and/or surgical treatment.  
Extrauterine Growth Restriction. EUGR is consistently diagnosed by assessing 
growth at < 10th percentile for age according to the growth curve utilized (Ohlin et al., 
2015).  The association between EUGR and the development of BPD is related to higher 
energy demands and insufficient intake, leading to poor lung healing and growth 
(Klevebro et al., 2019).  
The Fenton Growth Chart is a more comprehensive growth chart because: 1) 
thedata was derived from a systematic review and meta-analysis; 2) the data was 
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collected from  six developed countries; 3) the data was examined on infants from 22 
weeks’ until 36 weeks’ gestation; and 4) is synchronized with the WHO Growth Standard 
(Charles et al., 2019; Dravet-Gounot et al., 2018; Klevebro et al., 2019; Nyp et al., 2015; 
Fenton & Kim, 2013).  The benefit of syncing with the WHO growth standard includes 
consistency of growth assessment, compares with full term peers, and does not 
necessitate the use of a different growth chart (CDC, 2010). 
NICU Care and Interventions  
Doses of Surfactant. Surfactant is a lipoprotein that reduces pulmonary surface 
tension (Halliday, 2008). Administration of exogenous surfactant has been standard of 
care to treat RDS since 1990 (NORD, 2004). Higher numbers of surfactant dosing are 
associated with the development of BPD among preterm infants (Dravet-Gounot et al., 
2018; Guo et al., 2015; Hofer et al., 2013; Torchin et al., 2016). The relationship between 
BPD and surfactant dosing is likely multifactorial and includes prematurity, lack of 
surfactant, and arrested lung development (Bancalari & del Moral, 2001; Demirel et al., 
2009). Empirical indicator for this variable was the total number of surfactant doses 
administered to the infant.  
Transfusions. Higher number of packed red blood cell transfusions was 
associated with development of BPD (Demirel et al., 2009). There are several proposed 
mechanisms for this association including 1) damage from excessive heme oxygenase (a 
by-product from heme breakdown); 2) the role of transfusion-related acute lung injury 
(TRALI); and/or 3) an acute inflammatory response that negatively impacts the lungs 
(Zhang, Huang, & Lu, 2014). The empirical indicator for this variable was the total 
number of packed red blood cell transfusions found in all data sources (CHND, BCH 
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medical record, and/or outside medical record). While there are several types of blood 
components that are transfused, the systematic review of the literature focused on the 
association between BPD packed red blood cells. Therefore, packed red blood cells are 
the only blood component examined in this research and will be referred to as 
transfusions for the remainder of the study. 
Duration of Mechanical Ventilation. Premature lungs often lack the ability to 
adequately exchange gasses efficiently due to immature alveoli and lack of energy 
required to do the work of breathing. Therefore, mechanical ventilation is often required 
to assist premature infants with their work of breathing and gas exchange. However, there 
are side effects to mechanical ventilation including pressure and volume related trauma, 
and oxygen toxicity. These side effects can incur a risk of inflammation (Abman et al., 
2017; Laughon et al., 2011). Gentle forms of ventilation are a method to reduce pressure 
and volume-associated trauma but implementing these strategies have not led to a 
decrease in the incidence of BPD (Ehrenkranz et al, 2005; Jobe & Bancalari, 2001). 
Empirical indicators for this variable was the total duration of mechanical ventilation (in 
days) which included non-invasive ventilation duration (in days) and invasive ventilation 
duration (also in days).  
Normal Line of Defense: Bronchopulmonary Dysplasia   
The normal line of defense represents the usual health state of the client (Fawcett 
& Neuman, 2011). Testing this mid-range theory of BPD risk could lead to the 
development of a flexible line of defense by developing interventions that could decrease 
the risk of BPD. As the severity of BPD worsens, the abnormal pulmonary, 
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neurodevelopmental, and growth outcomes worsen (Abman et al., 2017; Ehrenkranz et 
al., 2006). A diagnosis of BPD has significant concomitant health, economic, and societal 
costs (Abman et al., 2017; Laughon et al., 2011), thus identification of those at risk is 
critical.   
The most recent and applicable BPD risk assessment tool includes gestational age, 
birth weight, oxygen concentration, respiratory support, race/ethnicity, and sex. These 
components determine the probability of developing no BPD, mild BPD, moderate BPD, 
and severe BPD (combined types 1 and 2) (Laughon et al., 2011).  To determine if the 
tool was more accurate on specific days of life, it was tested on multiple days (days 1, 3, 
7, 14, 21, and 28) (Laughon et al., 2011).  The tool was most accurate when used on day 
of life 28. While this risk assessment tool can be used, the variables of the tool do not 
include all of the variables from the mid-range theory.   
Long term consequences of BPD can affect the infant, family, and society 
including physical, psychological, and economic impacts. The health ramifications of 
BPD on infants are significant and become more significant as the grading progresses 
from mild to severe. Some of these ramifications include pulmonary hypertension, poor 
growth, and neurodevelopmental impairment (Abman et al., 2017). Mothers of infants 
with BPD have poorer sleep quality, higher stress, and higher rates of depression (Feeley 
et al., 2014). Parents of infants with severe BPD perceive their infants’ health-related 
quality of life as lower when compared to parents that have full term infants or preterm 
infants that do not have severe BPD (Brady, Zhang, Kirplani, & DeMauro, 2019). 
Finally, the economic impact of BPD is nebulous but incurs a greater cost than that of 
healthier preterm infants. There is no information on the long-term costs of BPD or the 
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costs  associated with comorbidities such as neurodevelopmental impairment, poor 
growth, or pulmonary hypertension (Johnson, Patel, Jegier, Engstrom, & Meier, 2013; 
Lapcharoensap, Lee, Nyberg, & Dukhovny, 2018).  
Conclusion 
 The mid-range theory, as guided by the NSM (see Figure 1), highlights 
extrapersonal, intrapersonal, and interpersonal stressors as represented by the empirical 
indicators discussed. These stressors were associated with the development of BPD in the 
systematic review of the literature. The next section of this dissertation includes a 
discussion of the study aims, hypotheses, and plan for post hoc analysis if there is 
sufficient sample size. 
Study Aims and Hypotheses 
Aim 1: To describe the sample of infants with BPD. 
Aim 2: Examine the association of BPD development and the predictive variables, based 
on the developed mid-range theory.  
Aim 2 Hypothesis 1: The presence of BPD will be higher among male infants, born at 
lower gestational ages, and born with lower birth weights. 
Aim 2 Hypothesis 2: The presence of BPD will be higher for infants with fetal growth 
restriction, and whose mothers were diagnosed with hypertension and chorioamnionitis.  
Aim 2 Hypothesis 3: The presence of BPD will be higher for infants with multiple doses 
of surfactant, multiple transfusions of packed red blood cells, and with a longer duration 
of mechanical ventilation.  
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Aim 2 Hypothesis 4: The presence of BPD will be higher for infants with multiple 
episodes of pneumonia, sepsis, meningitis, and urinary tract infections.  
Aim 2 Hypothesis 5: The presence of BPD will be higher for infants with PDA, PDA 
requiring medical management, and PDA requiring surgical closure.  
Aim 2 Hypothesis 6: The presence of BPD will be higher for infants with ≥ Stage 2 NEC. 
Aim 2 Hypothesis 7: The presence of BPD will be higher among infants with extrauterine 
growth failure.  
Post Hoc Analyses 
Provided that the sample was large enough, and that missing data was not an 
issue, two post hoc analyses were conducted. The first sought to examine the association 
between BPD and race/ethnicity, as previous research studies have had conflicting 
results. The second post hoc analysis was to examine the association of each grade of 
BPD (no BPD, mild BPD, moderate BPD, severe BPD type 1, and severe BPD type 2) 




















This cohort study was a secondary analysis of data from the Children’s Hospital 
Neonatal Database (CHND) as well as data collected from Boston Children’s Hospital 
(BCH) medical records and medical records from other institutions that were previously 
entered into the BCH medical record. The data sought from this database were only from 
infants treated at Boston Children’s Hospital, a referral center, and not a delivery 
hospital. To determine the outcome and grade of BPD, data regarding mechanical 
ventilation was required. Data of mechanical ventilation that was collected for the CHND 
was available beginning in 2010, therefore data analysis for this study included the years 
from January 2010 - January 2020. Study variables are described in Table 3. A data 
abstraction tool based on the mid-range theory (see Figure 1) is shown in Table 4. 
Further, a manual of definitions was employed to ensure consistency in operational 
definition characterizations (Vassar & Holtzmann, 2013).  
Study Sample 
The CHND was analyzed with the primary inclusion criteria of being an infant 
born at < 32 weeks’ gestation.  Exclusion criteria included inability to determine the 
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outcome of BPD and several conditions detailed in the section below (also see Table 5). 
These covariates were selected based on their potential confounding effect on the 
outcome of BPD.   
Excluded Covariates 
There are similar pulmonary signs and symptoms associated with BPD and 
congenital renal disease. In congenital renal disease the pulmonary signs are typically due 
to two major factors.  The first factor is oligohydramnios (low amniotic fluid volume 
during pregnancy), which prevents normal fetal lung development.  Enlarged kidneys is 
the second factor.  Through their mass-effect, enlarged kidneys impede effective 
ventilation and is an additional etiology for abnormal pulmonary signs and symptoms 
found in infants with congenital renal disease (Rodriguez, 2014). Given these 
confounding factors, infants with congenital renal disease are generally excluded in BPD 
research.  Infants with major congenital heart disease were also excluded.  Depending on 
the physiology of the diagnosis, increased pulmonary blood flow can lead to abnormal 
pulmonary manifestations secondary to a cardiac etiology and not from pulmonary 
disease. Therefore, infants with major congenital heart disease were excluded. Finally, 
infants with neuromuscular disorders, metabolic disorders, and other major congenital 
anomalies were excluded from this research.  Infants with these diagnoses frequently 
require mechanical ventilatory support due to poor muscular tone and/or abnormal 
neurologic function (Abman et al., 2017).   
Ethical Considerations 
The study design was a secondary analysis of deidentified CHND data. Other 
sources included data retrospectively collected from the BCH medical record and outside 
35 
 
hospital records.   Institutional Review Board (IRB) approval was obtained from Boston 
Children’s Hospital (IRB-P00035001) and the University of Massachusetts Boston (IRB 
Number 2020074).  Data was electronically abstracted from CHND and entered into a 
REDCap database. Data for variables that were not included in the CHND were collected 
by a single data collector (the student PI) from the BCH medical record and/or the 
outside hospital record. When the data retrieval was completed, each research subject was 
assigned a unique identification number in REDCap. A log of subjects’ medical record 
numbers and their identification numbers were stored in a separate file on a BCH 
computer behind the BCH firewall. The REDCap database was stored behind the BCH 
firewall in a password protected file. De-identified data was transferred in an Excel file. 
Measures 
 As previously stated, data was obtained primarily from the CHND. When not 
available in the CHND, data was collected using the BCH medical record and/or the 
outside hospital records. Together they will be referred to as all data sources. If there was 
a discrepancy between the CHND and the BCH medical record the outside hospital 
record was reviewed to verify data accuracy. 
Extrapersonal Stressor 
Sex 
 Sex was documented in the database as either male, female, or unknown. 
Race/Ethnicity 
The variables for race were Asian, Black, White, American Indian, Native Pacific 
Islander, other, and unknown. The variables for ethnicity include Hispanic, non-Hispanic, 




Interpersonal risks comprised the prenatal environment and included 
inflammation, infection, and MVU variables.  
Prenatal Inflammation and Infection 
When risk factors for BPD development were examined in a recent systematic 
review, inflammation and infection were often found in concert. Clinically, inflammation 
was represented by chorioamnionitis. As previously discussed, chorioamnionitis can be 
diagnosed histologically and/or clinically. The database did not differentiate between 
histologic or clinical chorioamnionitis. Rather, chorioamnionitis was either diagnosed or 
not diagnosed for each subject. The empiric indicators for these variables were either yes 
(present) or no (not present). 
Maternal Vascular Underperfusion 
Placental pathology was not collected as part of the data in the CHND. The 
database did identify whether the mother had clinical evidence of MVU represented by 
maternal chronic hypertension, gestational hypertension, HELLP syndrome, and/or 
preeclampsia. The empiric indicators for this variable was either yes (present) or no (not 
present). 
Fetal Growth Restriction 
Fetal growth restriction was assessed by plotting the birth weight on the Fenton 
growth chart (Fenton & Kim, 2013) and any infant with a birth weight less than 10th 
percentile considered to have fetal growth restriction, and was entered as “yes” during 
data collection. If the birth weight was > 10th percentile based on gestational age, then 




 Intrapersonal stressors included infant characteristics (gestational age, birth 
weight, patent ductus arteriosus, and extrauterine growth failure) and NICU 
interventions. The NICU interventions included doses of surfactant, number of 
transfusions, duration of mechanical ventilation. 
Infant Demographics 
Infant demographics that increase risk of BPD included gestational age, and birth 
weight.  
Gestational Age and Birth Weight. Gestational age was measured using 
completed weeks of gestation. Birth weight was measured in grams.   
Postnatal Inflammation. Risks for inflammation were represented by duration of 
mechanical ventilation, due to oxidative stress, and with NEC. Duration of mechanical 
ventilation was measured in number of days. NEC was measured as yes if the infant was 
diagnosed with NEC (see Table 2) and if they have findings on radiograph consistent 
with ≥ Bell’s Stage 2 (Bell et al., 1978).  Data for NEC was categorized in the database 
by the location of its occurrence, referring hospital or BCH. Medical and surgical NEC 
fulfilled the requirements for Bell’s stage ≥ 2, so both variables were included in the 
analysis as “yes” if diagnosed an “no” if they were not diagnosed 
Postnatal Infection. Laboratory samples indicative of infection were positive 
cultures. Positive blood cultures are considered diagnostic for bacteremia. Positive urine 
cultures were diagnostic for urinary tract infections. Positive cerebral spinal fluid 
cultures. were indicative of meningitis. Per the CHND. Pneumonia was diagnosed if the 
following were demonstrated: 1) worsening gas exchange as evidenced on blood gasses; 
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2) worsening appearance of the lungs on chest radiographs obtained at two different time 
points; and 3) a combination of several other signs and symptoms (fever and elevated 
white blood cell count, for example). Each diagnosis of infection was measured as 
separate occurrences and the cumulative number of infections was used for analysis. 
Patent Ductus Arteriosus. The CHND collected multiple variables for PDA. 
This first included either if there is a diagnosis of PDA determined during hospitalization 
or if there is no diagnosis made during hospitalization.  If a diagnosis of a PDA was 
determined, using echocardiography, it was further defined into other variables which 
included no treatment, medical treatment, or surgical treatment. The variables collected 
for this research were: 1) PDA diagnosis (yes or no), 2) treatment required for 
management of the PDA, if any; and 3) what type of treatment(s) were required.  
Extrauterine Growth Failure. If available, the CHND collected weights at 
several time points for infants born < 32 weeks (i.e., at birth, 28 days of life, 36 weeks 
PMA, 40 weeks PMA, and 44 weeks PMA). If the infant remained in the NICU at BCH, 
the 50-week weight was collected, using data from the BCH medical record. Consistent 
with assessing for FGR, EUGR was measured with a yes if the infant was assessed as 
<10th percentile in weight for their gestational age, or no if they were not <10th percentile 
for age (Fenton & Kim, 2013). Given that subjects are admitted and discharged from 
BCH at different time points, the last weight collected was used to determine whether a 
subject was EUGR.  
NICU Interventions 
Doses of Surfactant. The CHND collected whether a subject received surfactant, 
or not as their surfactant variable.  The other data sources were searched for the precise 
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number of surfactant doses. For the purposes of this research, the total number of 
surfactant doses was used as the empirical indicator for this variable 
Transfusions. The CHND did not include data regarding transfusions. Therefore, 
other data sources were searched for the number of transfusions administered. Due to the 
wide range in the number of transfusions administered, the transfusions were grouped 
into equal proportional groupings for the analysis: 1) group one received zero 
transfusions, 2) group two received either one or two transfusions, 3) group three 
received between three to six transfusions, and 4) group four received more than six 
transfusions. A fifth group was added to account for the infants with missing transfusion 
data.  
Duration of Mechanical Ventilation. Duration in mechanical ventilation was 
measured in total days.  To further categorize mechanical ventilation data, the total 
duration of mechanical ventilation was separated into non-invasive and invasive 
mechanical ventilation (total days).   
Normal Line of Defense 
BPD Diagnosis and Grading  
BPD diagnosis was determined using the diagnostic criteria developed in 2000 
[see Table 1] (Jobe & Bancalari, 2001). For this research, a diagnosis of BPD was 
established based on oxygen requirement at 28 days of life and respiratory support 
requirements at 36 weeks ± 2 weeks.  
Data Analysis 
An ‘a priori’ p value for statistically significant findings was set at 0.05. Power 




The first aim was to describe the infants in the study.  To describe the study 
sample and determine the distribution of the sample’s data, a univariate analysis of each 
concept was conducted. Gestational age and birth weight were not normally distributed, 
so the median and interquartile range were reported. For race and ethnicity and sex, 
frequency and percentage were reported.   
Aim 2 
To examine the bivariate association of BPD development (yes or no) and the 
predictive variables, Chi-square test was used to examine the association between BPD 
and the categorical variables (fetal growth restriction, chorioamnionitis, maternal 
vascular underperfusion, patent ductus arteriosus, treatment of patent ductus arteriosus, 
NEC, and extrauterine growth restriction). Wilcoxon Signed Ranks was used to test the 
association between BPD and the continuous variables (doses of surfactant, number of 
transfusions, duration of mechanical ventilation, episodes of infection). Bivariate analysis 
and multivariate binary logistic regression were conducted to determine the association 
between the outcome variable of BPD and the independent variables.  
Post Hoc Analyses  
Two post hoc analyses were planned, but due to insufficient representation of all 
the race/ethnicity categories, only one was performed.   Examining the association 
between development of BPD and race/ethnicity had been conflicting in the literature 
(Janevic et al., 2018).  Therefore, the first post hoc analysis was planned to explore the 
relationship between race, ethnicity, and BPD. However, there was insufficient 
41 
 
representation of all race/ethnicity categories so this post hoc analysis could not be 
performed.  
The second post hoc analysis was to explore the relationship between the risk 
factors and each grade of BPD (see Table 1). There were many infants in this sample that 
were diagnosed with BPD, so this analysis could be performed. To examine the 
association of race, ethnicity, and each grade of BPD (see Table 1) and the categorical 
predictive variables, use of Chi-square test was planned. Wilcoxon Signed Ranks test was 
planned to test the association between race, ethnicity, and each grade of BPD and 
continuous variables.  Predictive variables with p < 0.05 from the bivariate analysis was 
entered into multinomial logistic regression, with the dependent variables as each grade 






















 The purpose of this study was to examine the extrapersonal, interpersonal, and 
intrapersonal stressors as identified in a systematic review that is predicted to affect the 
development of BPD. The organization of the risk factors and analysis of this study was 
guided by the NSM (2011), a holistic systems approach.  The specific aims of this study 
were to (1) describe the sample of infants with BPD in the BCH CHND and (2) examine 
the association of BPD development and the predictive variables, based on the mid-range 
theory (see Figure 1).   
Describing the Sample 
Between 2010 and 2020, there were 645 infants born at < 32 weeks’ gestation 
admitted to the NICU at BCH and entered into the CHND.  After identification in the 
CHND, their medical records were screened following inclusion/exclusion criteria (see 
Table 5). Infants were excluded if they were diagnosed with major congenital anomalies 
(n=122), the presence of congenital renal disease (n=11), neuromuscular disorders (n=2), 
and a metabolic disorder (n=1), or if the diagnosis of BPD could not be determined 
(n=54), After screening for inclusion/exclusion criteria a final sample of 455 infants 
remained (see Figure 2).  
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Description of the sample of infants from the CNHC, born at <32 weeks’ 
gestation was completed to address Aim 1.  
Frequency and percentages were used to summarize race, ethnicity, sex, FGR, 
chorioamnionitis, MVU, transfusions, PDA, and NEC (Table 6 and 8).  Infant weights 
(measured in grams), gestational ages (measured in weeks), non-invasive mechanical 
ventilation (measured in days), invasive mechanical ventilation (measured in days), and 
total mechanical ventilation (measured in days) were not normally distributed, thus 
median and interquartile ranges were calculated (see Table 6).  Infection frequency and 
percentage are presented in Table 7.  
Extrapersonal Stressors 
As depicted in Table 6, the ethnicity of the infant was unknown for 133 records, 
and race was unknown for 96 records. Of those infants with known race and ethnicity, the 
majority were white non-Hispanic, or Latino. There were more male infants than female 
infants in the sample. 
Interpersonal Stressors 
Most pregnancies in this sample were not affected by FGR, chorioamnionitis, or 
MVU (see Table 6).   
Intrapersonal Stressors 
Gestational Age and Birth Weight 
The majority of infants in the sample were born at younger gestational ages and 
had lower birth weights. The median gestational age for subjects was 26 weeks, with a 





Type of infection and total infections in each subject (see Table 7) was as follows: 
blood stream infections were diagnosed most frequently (27%), followed by pneumonia 
(25.1%), urinary tract infections (13.2%), and meningitis (6.2%).  When examined as 
total number of infections per each subject, the median was 1 with IQR 0, 1; 
approximately half of all subjects had at least one infection (50.8%).   
Patent Ductus Arteriosus and Necrotizing Enterocolitis 
Greater than half of the subjects were diagnosed with a PDA, and the majority 
required medical and/or surgical treatment.  There was also a group of infants that 
required both medical and surgical treatment (see Table 8).  
NEC was diagnosed in approximately one-third of study sample requiring medical and/or 
surgical management, with the majority requiring surgical treatment (see Table 8).  
NICU Interventions Required to Treat Infant Characteristics  
Surfactant. The majority of infants received surfactant (77%), with a range of 0-4 
doses.  Most of the subjects received one dose of surfactant.  
Transfusions. All data sources for each subject were searched for a history of 
receiving transfusion. Of the total sample of 455 infants, data for 314 subjects was 
obtained.  For a more meaningful analysis because of missing data, transfusion groups 
were created (see Table 9). Group one had zero transfusions (n=78), group two (n= 74) 
were transfused either once or twice, group three (n=86) received between three to six 
transfusions, group four (n=76) had ≥ 7 transfusions. There were 141 subjects for whom 
the exact number of transfusions could not be determined despite searching all the data 
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sources, A fifth transfusion group was created to include these subjects with missing 
transfusion data.    
Mechanical Ventilation. The days of non-invasive mechanical ventilation, 
invasive mechanical ventilation, and total mechanical ventilation were not normally 
distributed due to a subset of the subjects with significantly longer duration of 
mechanical ventilation (see Table 6). Of those subjects requiring mechanical ventilation: 
the median for non-invasive ventilation was 25 days, invasive ventilation 32 days, and 
the total duration of mechanical ventilation had a median of 63 days.   
Normal Line of Defense 
 Of the 455 subjects included in this study, 83.7% were diagnosed with BPD with 
the majority diagnosed with Severe BPD [type 1 or 2] (see Table 10).  
Bivariate Analysis of BPD Development and the Predictor Variables 
 Aim two examined the association between BPD and the predictor variables in the 
study. The hypotheses were that BPD was associated with the predictive variables. 
Further, it was hypothesized that variables from more than one stressor (extrapersonal, 
interpersonal, and intrapersonal) would increase the risk for BPD.   
 First, bivariate analysis between each predictive variable and the development of 
BPD were conducted. Variables with statistically significant (p < 0.05) associations with 
BPD development were then entered into binary logistic regression analysis.  
BPD Diagnosis and the Association with Race, Ethnicity, and Sex 
Race, as a combined variable including all variables of races, did not have a 
statistically significant relationship with BPD diagnosis (X2 = 11.33, df 8, N = 455, p = 
0.18). There were seven categories within the race variable: White, Black/African 
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American, Asian, Native American, Native Hawaiian, other, and unknown. For all of the 
categories, Chi-Square analyses were performed to determine if a statistical association 
with BPD existed (see Table 11). Only White (n = 218, p < 0.01) and other (n = 49, p = 
0.01) were statistically significant.  
The majority of subjects were not Hispanic, and this variable was found not to 
have a statistically significant relationship with BPD (X2 = 5.79, df 2, N = 322, p = 0.06).  
While there were more male subjects, there was no statistically significant association 
between BPD and sex (X2 = 1.21, df 1, N = 455, p = 0.27). 
BPD and the Association with Chorioamnionitis, MVU, and FGR 
 Chi-Square tests were used to examine associations between the diagnosis of BPD 
and chorioamnionitis, MVU, and FGR (see Table 12).  Of these conditions, FGR was the 
only variable to have a statistically significant relationship with BPD (X2 =7.38, df 2, N = 
81, p = 0.03). 
BPD Diagnosis and the Association with Gestational Age and Birth Weight 
 Table 13 depicts the bivariate analysis of the intrapersonal stressors with BPD. 
Using Wilcoxon Signed Ranks test for both, subjects born at lower gestational age were 
more likely to develop BPD (p < 0.01), as were infants with lower birth weights (p < 
0.01).  
BPD Diagnosis and the Association with Surfactant, Transfusions, and Mechanical 
Ventilation 
 The association between surfactant administration, transfusions, and duration of 
mechanical ventilation were all continuous variables, so they were analyzed using the 
Wilcoxon Signed Ranks. Each of the variables were statistically associated with BPD 
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(see Table 13). More doses of surfactant administered was associated with the 
development of BPD (p < 0.01). The number of transfusions varied from 0-41, so they 
were grouped into four equal groups (group 1 with n=78, group 2 with n=74, group 3 
with n=86, and group 4 with n=76). There were 141 missing data for transfusions, which 
were grouped into a fifth group. Higher number of transfusions and BPD has a 
statistically significant association (p < 0.01). The longer the duration of mechanical 
ventilation was associated with BPD development (p < 0.01). This association was also 
true for invasive and non-invasive ventilation duration.  
BPD Diagnosis and the Association with Postnatal Infections 
 Risk for BPD and its association with pneumonia, blood stream infection, 
meningitis, and urinary tract infections were analyzed using Wilcoxon Signed Ranks (see 
Table13). Neither blood stream infections nor meningitis were statistically significant. 
Pneumonia was associated with the development of BPD (p < 0.01), as was urinary tract 
infections (p<0.01). Furthermore, the association between total number of infections and 
BPD was also tested and demonstrated that increased number of infections was 
associated with development of BPD (p < 0.01). 
BPD Diagnosis and the Association with PDA 
 The association between BPD and diagnosis of a PDA was analyzed using Chi-
Square test and was found to be statistically significant (X2 = 56.26, df 2, N= 455, p < 
0.01). This group was further analyzed, looking at the four variables associated with a 
diagnosis of a PDA: 1) no treatment, 2) medical treatment, 3) surgical treatment, or 4) 
medical and surgical treatment. PDA diagnosis was examined as a categorical and 
interval level variable (see Table 13). PDA diagnosis was examined as interval since each 
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increasing treatment category has more implications for the infant (no treatment, medical 
treatment, surgical treatment, and both medical and surgical treatment). The association 
between BPD and no treatment for their PDA was not statistically significant. However, 
the other three groups did demonstrate statistically significant results. First, the two 
methods of treatment were analyzed.  Medical treatment was associated with the 
development of BPD (X2 = 36.6, df 1, N = 455, p < 0.01), as was surgical management 
(X2 = 19.45, df 1, N= 455, p<0.01). Finally, the association between BPD and both 
medical and surgical management was evaluated and found to be associated with the 
development of BPD (X2 = 12.07, df 1, N = 455, p < 0.01).  Finally, all variables of PDA 
were combined, and its association with BPD was tested. The combined variable was 
associated with BPD (X2 = 62.79, df 5, N = 455, p < 0.01) with a medium effect (phi = 
0.44).  
BPD Diagnosis and the Association with NEC 
 The association between a diagnosis of Stage ≥ 2 NEC and BPD was analyzed 
using Chi-Square test. The diagnosis of Stage ≥ 2 NEC and BPD was statistically 
significant (X2 = 20.02, df 2, N = 455, p < 0.01). Treatment of Stage ≥ 2 NEC and the 
association with BPD was analyzed: 1) medical treatment, 2) surgical treatment, and 3) 
medical and surgical treatment. Like PDA, NEC diagnosis was examined as a categorical 
and interval level variable (see Table 13). NEC diagnosis was examined as interval since 
each increasing treatment category has more implications for the infant (medical 
treatment, surgical treatment, and both medical and surgical treatment). The association 
between BPD and medical management was statistically significant (X2 = 3.95, df 1, N = 
455, p = 0.05). The association between surgical management and BPD development was 
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also statistically significant (X2 = 13.88, df 1, N =455, p < 0.01). Finally, management 
with medical and surgical treatment was also found to be statistically significant (X2 = 
4.06, df 1, N = 455, p = 0.04) 
BPD Diagnosis and the Association with EUGR 
 The Independent -Sample Mann-Whitney U Test was used to analyze the 
association with weight (in grams) and BPD at 28 days of life, 36 weeks’ gestation, 40 
weeks’ gestation, 44 weeks’ gestation, and 50 weeks’ gestation. However, there was a 
significant amount of missing data from each category. The association between EUGR 
and BPD development was assessed using data from the last available weight using the 
Chi-Square test. EUGR and the development of BPD was found to be statistically 
significant (X2 = 20.19, df 2, N = 455, p < 0.01).  
Correlation Matrix 
 A correlation matrix was performed to demonstrate if there were significant 
correlations between the independent variables in this study. Findings demonstrated 
many correlated independent variables in the study (see Table 14). There were multiple 
correlated variables. 
Binary Logistic Regression 
 The bivariate analysis of the predictor variables demonstrated that there were 
significant variables in each of the extrapersonal, interpersonal, and intrapersonal 
stressors. Extrapersonal stressors with p< 0.05 included variables of White and Other. 
Ethnicity did not have a statistically significant relationship with development of BPD. 
Of the interpersonal stressors, only FGR was statistically significant. Finally, of the 
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intrapersonal stressors, many were statistically significant and evaluated further in the 
regression analysis. 
 Table 15 depicts the results from the binary logistic regression. While variables 
from the extrapersonal, interpersonal, and intrapersonal stressor categories were entered 
into the analysis, only intrapersonal stressors remained statistically significant. Lower 
birth weight was associated with development of BPD (OR 0.99, p = 0.04; 95% CI 
[0.993, 1.00]). Patients that received more doses of surfactant were more likely to 
develop BPD (OR 2.49, p <0.03; 95% CI [1.1, 5.77]). Finally, patients that were on 
mechanical ventilation for longer duration were more likely to develop BPD (OR 1.2, p < 
0.01; 95% CI [1.12, 1.27]).   
Post Hoc Analysis 
The role of race/ethnicity and the development of BPD was not further examined 
since there was an insufficient representation of Black/African American, Asian, Native 
American, Native Hawaiian races in the sample.   
The majority of infants in this study were diagnosed with BPD (n=381, 83.7%).  
More than half of those with BPD had Severe Type 1 or 2 BPD (see Table 10). The post 
hoc analysis examining grades of BPD and the predictive variables was conducted.  First, 
a bivariate analysis was performed using Chi-square test to examine the association 
between BPD grade and the categorical variables. Wilcoxon Signed Ranks test was used 
to test the association between BPD grade and the continuous variables.   
Bivariate Analysis of the Predictive Variables and Grades of BPD Severity 
Chi-Square was used to analyze the categorical variables (see Table 16). Among 
the variables of race, White (X2 =12.58, df, 4, N =455 , p = 0.01) and Asian (X2 = 17.73, 
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df 4, N = 455, p < 0.01) were significantly associated with worsening severity of BPD. 
The combined sample category was also statistically significant (X2 = 57.715, df 32, N = 
455, p < 0.01). Among the interpersonal stressors, only FGR was statistically significant 
(X2 = 29.07, df 4, N = 455, p < 0.01), with a medium effect (see Table 17).  All variables 
of PDA and NEC were statistically associated with severe grade of BPD (X2 = 89.34, df 
16, N = 455, p < 0.01; X2 = 39.25, df 16, N = 455, p < 0.01). PDA had a large effect size 
and NEC had a medium effect size. EUGR was also statistically significant with a 
medium effect size (X2 =26.916, df = 4, N = 455, p < 0.01).  Table 18 represents these 
results. 
Continuous variables were analyzed using Wilcoxon Signed Ranks. Birth weight 
and gestational age were both statistically significant (U = -18.4, p < 0.01; U = -18.51, p 
< 0.01). Doses of surfactant was statistically significant (U = 17.03, p < 0.01). Total days 
of mechanical ventilation is a continuous variable (U = -18.237, p < 0.01). Total 
infections and transfusion groups were also statistically significant (U = -17.724, p < 
0.01; U = -7.13, p < 0.01). 
Multinomial Logistic Regression Analysis 
Multinomial logistic regression was conducted in the post hoc analysis. The 
outcome variable was categorized into five categories: no BPD, mild BPD, moderate 
BPD, severe BPD (type 1), and severe BPD (type 2). Independent variables with p < 0.05 
from the bivariate analysis (see Tables 16, 17, and 18) were entered into the  multinomial 
regression analysis.  Based on this analysis race, FGR, gestational age, birth weight, 
doses of surfactant, total days of mechanical ventilation, total infections, transfusion 
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groups, all variables of PDA, all variables of NEC, and EUGR were statistically 
significant and entered into the multinomial logistic regression analysis.  
Table 19 depicts the significant relationships with mild BPD included total days 
of mechanical ventilation (OR = 1.16, p < 0.01; 95% CI [1.1, 1.24]), total infections (OR 
0.36, p = 0.03; 95% CI [0.14, 0.9]), and NEC variables (OR = 2.17,  p = 0.03; 95% CI 
[1.09, 4.35]). Table 20 demonstrates the variables with significant relationships to 
moderate BPD. These include doses of surfactant (OR = 2.48 p = 0.04; 95% CI [1.04, 
5.89]), total days of mechanical ventilation (OR 1.15, p < 0.01; 95% CI [1.09, 1.22]), 
total infections (OR 0.36, p = 0.04; 95% CI [0.14, 0.94]), and PDA variables (OR 3.35, p 
= 0.01; 95% CI [1.27, 8.84]).  
Table 21 demonstrates the statistically significant findings for Severe (Type 1) 
BPD and the predictive variables.  Variables with a statistically significant association 
with Severe Type 1 BPD include gestational age, birth weight, doses of surfactant, total 
days of mechanical ventilation, and all variables of PDA.  Finally, Table 22 depicts the 
association between Severe (Type 2) BPD and the predictive variables. Of the variables 
entered in the multinomial logistic regression analysis, six were statistically significant. 
The variables associated with development of Severe (Type 2) BPD included gestational 
age, doses of surfactant, total duration of mechanical ventilation, and all variables of 
PDA.  
The only variable that was consistent across all grades of BPD was total duration 
of mechanical ventilation. Total infections were associated with mild and moderate BPD. 
As the grade of BPD worsens, more variables were statistically significant. For moderate, 
severe type 1, and severe type 2 BPD doses of surfactant, PDA was associated with the 
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The sample in this study (n = 455) was treated at a Level IV NICU. All infants 
treated in this NICU were transferred to the facility due to need for a higher level of care 
such as a surgical procedure or a complication related to their preterm birth.  This is a 
select sample of preterm infants and they are among the most complex infants cared for 
in the NICU. The purpose of this chapter is to interpret the findings of this research in 
context of contemporary knowledge of BPD and the mid-range theory, which was 
developed using the NSM (Fawcett & Neuman, 2011). The findings provide an 
opportunity to improve future practice and research. Limitations to this research study are 
also discussed. 
Extrapersonal Stressors 
The male fetus has delayed surfactant production due to hormonally based 
differences which leads to an increase resistance in the alveoli and control in the budding 
of the bronchioles during early fetal development (Shim et al., 2017). While male sex has 
historically been a risk factor for the development of BPD (Abman et al., 2017), this was 
not the case in this study.  Perhaps the findings from this research demonstrate that there 
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is a moderating effect due to other conditions, such as PDA or NEC that change this 
long-established relationship.  
Ethnicity was not statistically associated with BPD development, however 
approximately one-third of subjects’ ethnicities were not reported. While the race 
variables of White and other were associated with BPD development in bivariate 
analysis, this relationship was not demonstrated in binary logistic regression analysis. If 
there had been more subjects with race and ethnicity reported, there may have been 
different results.  
Interpersonal Stressors 
Interpersonal stressors included chorioamnionitis, MVU, and FGR.  In the 
bivariate analysis, only FGR had a significant relationship with BPD. Given the 
association found in the literature between chorioamnionitis and MVU, the measures 
were examined in this sample. Maternal hypertensive disorders were the empirical 
indicator for MVU, consistent with the literature (Mestan et al., 2014; Mestan et al., 
2017).  However, other signs of MVU may include placental insufficiency, and reversal 
end diastolic flow, and chronic placental insufficiency Mestan et al., 2014; Mestan et al., 
2017). As these conditions impact placental blood flow, and may impact fetal lung 
development they should be included as variables in future research. Finally, it should be 
noted that sufficient representation in this category of stressors may have been 
underrepresented since MVU and chorioamnionitis are not typical indications for transfer 






Gestational Age and Birth Weight 
Generally, BPD incidence and severity increases as gestational age and birth 
weight decreases. Gestational age was significantly associated with severe BPD (type 1), 
and severe BPD (type 2). Birth weight was associated with a diagnosis of BPD, as well as 
severe BPD (type 1). These findings are consistent with past research findings (Dravet-
Guonot et al., 2018; Guo et al., 2015).  
Surfactant 
Exogenous surfactant is administered to preterm infants to bridge the gap in time 
between birth and when endogenous surfactant production is sufficient to facilitate 
adequate ventilation and oxygenation.  The timing of endogenous production varies 
depending on factors such as gestational age, maternal conditions, male sex  (Dravet-
Gounot et al., 2018; Guo et al., 2015; Hofer et al., 2013; Shim et al., 2017; Torchin et al., 
2016). Objective indications for an initial surfactant dose are prematurity and symptoms 
of RDS (see Table 2). Repeated doses can be administered (depending on formulation) 
several more times within the first days of life for continued signs of RDS including high 
oxygen requirements and high mean airway pressure. The additional doses facilitate 
ventilation and oxygen needs of the premature infant (Polin & Carlo, 2014).  In this study 
sample, reported increased doses of surfactant were associated with a higher likelihood of 
a BPD diagnosis, and specifically with moderate, severe type 1, and severe type 2 BPD. 
This is consistent with previous research (Dravet-Gounot et al., 2018; Guo et al., 2015; 
Hofer et al., 2013; Shim et al., 2017; Torchin et al., 2016).    
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The findings from this research suggest that the relationship between exogenous 
surfactant and BPD is more complex than surfactant deficiency alone. Perhaps the 
requirement of exogenous surfactant dosing is less due to surfactant production 
deficiency and is instead a signal for the “new BPD”, or maldevelopment of the lungs and 
pulmonary microvasculature.  Finally, a need for more surfactant dosing may also 
represent an inflammatory or infectious etiology which prevents endogenous surfactant 
production (Abman et al., 2017).   
Transfusions 
Transfusions are postulated to be associated with BPD through several 
mechanisms including 1) damage from excessive heme oxygenase; 2) the role of 
transfusion-related acute lung injury (TRALI); and/or3) an acute inflammatory response 
that negatively impacts the lungs (Zhang, Huang, & Lu, 2014). The majority of subjects 
received at least one transfusion, and transfusions was associated with BPD development. 
The role of transfusions in BPD can be examined in two ways. The first way is 
examining those infants that receive more transfusions; they are generally more ill than 
those that did not require multiple transfusions.  The infants that require more 
transfusions are more likely to have had surgical conditions, were unable to tolerate 
enteral feedings, and had less iron intake.  Whether BPD is caused by transfusions or a 
mark of infants with more complicated conditions are at higher risk for BPD remains to 
be researched.  
Mechanical Ventilation 
Mechanical ventilation has been associated with BPD since 1967 (Northway et 
al., 1967), and was again demonstrated in this sample. The use of mechanical ventilation 
58 
 
is a necessity to support the ventilation and oxygenation of preterm infants, but also 
incurs risks of oxidative injury, barotrauma, and volutrauma (Abman et al., 2017). Infants 
requiring a longer duration of mechanical ventilation may be a signal of maldevelopment 
in utero, that is then exacerbated by the treatment itself, and other conditions causing 
inflammation and/or infection. 
Patent Ductus Arteriosus 
Diagnosis of PDA was made in 62.4% of the infants in this study.  It is considered 
a natural finding in all infants, with higher incidence and longer duration of patency 
among preterm infants. Consistent with other research (Dravet-Gounot et al., 2018; 
Demirel et al., 2009; Guo et al., 2015; Rutkowska et al., 2019; Torchin et al., 2016), the 
findings of this study demonstrate a relationship between PDA diagnosis and 
development of BPD, including the development of severe grades of BPD.  Common 
practice is to treat a hemodynamically significant PDA, using guidance from 
echocardiography and clinical examination. Indications for treatment include a large 
PDA that is not responsive to medical interventions and/or a symptomatic PDA that 
causes hypotension and increased O2 requirement and increased ventilatory support.  
However, waiting for signs and symptoms to occur before treating the PDA may 
permit insidious pulmonary damage caused by overcirculation. Instead of waiting for 
signs of a hemodynamically significant PDA prior to echocardiography, closer 
surveillance, such as echocardiography and/or brain natriuretic peptide (BNP) 
measurement should be considered. More research is needed to determine when a PDA is 
no longer a naturally occurring condition and becomes harmful. The findings from this 
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research suggest that the impact of the PDA and its role in the development of BPD 
among premature infants deserves further exploration.   
Necrotizing Enterocolitis and Infections 
Pneumonia, urinary tract infections, and total number of infections were 
associated with the development of BPD in the bivariate analysis, but not in the binary 
logistic regression analysis.  Total infections were associated with the development of 
mild and moderate BPD in the post hoc analysis. Subjects with NEC were more likely to 
develop BPD. Demonstrating the role of inflammation and infection in the development 
of BPD.  Infection and NEC surveillance must continue as standard of care. Further, if 
infections and/or NEC are diagnosed, early BPD detection and risk reduction must be 
employed. 
Clinical sepsis, where the bacterial culture results were negative, but the patient 
demonstrated signs of an infection, has been highlighted as a risk for BPD (Hofer et al., 
2013; Ohlin et al., 2015).  Perhaps inclusion of cases of clinical sepsis would be useful in 
future research to explore the role of its associated inflammation.  
Extrauterine Growth Restriction 
EUGR is defined as weighing < the 10th percentile for age (Ohlin et al., 2015), 
and this variable was associated with BPD in bivariate analysis but not in binary logistic 
regression, nor in multinomial regression analysis.  While reviewing the last weight, 
which was used to determine EUGR, only those weights that were in the < 10th percentile 
classified EUGR. However, there were subjects whose weights decelerated significantly 
over the time between birth and the final assessment.  There are two considerations for 
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discussion: 1) what are the reasons for the decelerations in growth, and 2) is there a more 
comprehensive assessment to categorize extrauterine growth restriction?  
Growth restriction is an imbalance of metabolic demands and nutritional intake. 
Conditions associated with high metabolic demands include respiratory distress, 
infections, NEC, PDA, and more. Nutritional intake is in the form of parenteral and/or 
enteral nutrition, however providing nutritional intake to meet the dynamic needs of 
NICU patients is a challenge. The balance between metabolic demands and intake needs 
further exploration in the future. Comparing outcomes, using growth to define the groups, 
would aid in delineating the role of growth in outcomes, specifically the development of 
BPD.  
Next, the most appropriate measure for EUGR deserves further exploration. As an 
example, if an infant is born in the 75th percentile and then their weight decelerated to the 
15th percentile they were not classified as having EUGR based on the measurement 
selected.  However, this represents a significant deceleration in growth. Failure to thrive 
(FTT) is defined as a weight decline of ≥ 2 major percentiles on the growth chart at 
separate points of assessment (Cole & Lanham, 2011).  FTT is not a commonly applied 
definition for preterm infants; instead EUGR is more common. However, examining 
weight over time rather than only a one-time assessment could be an important area for 
future examination as it may be a better indicator of overall wellness in this population.  
Conclusion 
This research was framed using the NSM, a holistic systems approach (Fawcett & 
Neuman, 2011). A systematic review of the literature was conducted to explore the risk 
factors for BPD.  These risk factors were categorized into each of the NSM stressors: 
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extrapersonal, interpersonal, and intrapersonal (see Figure 1).  Initially there were 15 
variables (with subcategories) that were proposed to be associated with the development 
of BPD.  
BPD diagnosis and each grade of BPD were associated with total duration of 
mechanical ventilation. As severity of BPD increased, other variables increased risk 
including gestational age, birth weight, and PDA. Variables that were associated with 
BPD in bivariate analysis, but not in the regression analysis, deserve further exploration 
in future research. 
Implications 
The “new BPD” is characterized by an arrest in lung development, simplified 
alveoli, and a reduction in pulmonary microvasculature (Abman et al., 2017).  The 
development of this “new BPD” is multifactorial, demonstrated in the results of this 
research. Pediatric research has demonstrated a complex relationship between 
physiologic and psychologic stressors and the development of chronic diseases and 
conditions (Hornor, 2016). There were multiple stressors from the intrapersonal stressors 
that reflect risk(s) early in postnatal life (i.e., lower birth weight, gestational age, and 
need for surfactant dosing). This research demonstrates that there is ongoing evolution of 
the risks in the development of BPD. Multiple surfactant doses may be an early signal for 
the “new BPD” rather than being indicative of profound surfactant deficiency. Perhaps 
infants that require multiple doses of surfactant could benefit from early BPD reduction 
efforts, such as steroid administration. Also, infants with infections and/or NEC could 
benefit from early BPD reduction measures such as steroid administration.  Finally, 
systematic surveillance for PDA may lead to improved diagnosis of infants with early 
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signs of cardiovascular alterations, such as stretching of chambers.  Perhaps infants with 
these signs would benefit from early closure, thus reducing risk for BPD.  
Risks Without an Association with BPD 
Classically BPD diagnoses are more likely among male infants.  This was not the 
case in this study cohort.  Since the sample of subjects were transferred to BCH, they 
may not represent the total population of preterm infants. While they may represent a 
segment of NICU patients, these results may not be generalized to all preterm patients. 
Fetal growth restriction was measured using birth weight, but perhaps there is a more 
comprehensive measure such as decelerations in growth. MVU and chorioamnionitis 
were not associated with BPD in any of the analyses. For MVU, it is possible that 
maternal hypertension does not provide direct measure of MVU. Abnormal fetal doppler 
findings such as decreased, absent, or reversed umbilical artery end diastolic blood flow 
may provide a more direct measure of MVU for it is a sign of placental vascular 
dysfunction with consequences to the fetus (Mestan et al., 2014; Mestan et al., 2017; 
Taglauer et al., 2018).  Coupling maternal hypertension and abnormal fetal doppler may 
provide improved insight into the impact of MVU on the developing fetus, including its 
risk for development of BPD.  Further, arrest in fetal growth with abnormal fetal doppler 
findings have been proposed as indicative of FGR without including weight (Torchin et 
al., 2016).  Chorioamnionitis impacts pregnancies that result in preterm deliveries more 
than full term deliveries, with increasing incidence as gestation decreases (Fowler & 
Simon, 2020). Chorioamnionitis impacted 12.5% of pregnancies in this study, however 
the true impact is proposed to be between (8-50%) (Fowler & Simon, 2020).  Clinical 
chorioamnionitis was used to determine chorioamnionitis for this study, but histologic 
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chorioamnionitis could have led to a more comprehensive determination of the impact of 
chorioamnionitis on BPD diagnosis. Given that the subjects in the CHND are transferred 
from outside hospitals, histologic diagnosis of chorioamnionitis may not be entered into 
the CHND. Perhaps future studies can examine histologic and clinical chorioamnionitis 
in relation to BPD. While the transfusions were positively associated with BPD diagnosis 
and higher grade of BPD, it did not continue to have a statistically significant association 
in the regression analyses.  Transfusions may be related to comorbidities. 
Limitations 
There are several limitations to this study.  The data in this study was obtained 
retrospectively and employed secondary analysis of the CHND. Despite an extensive 
review of all data sources, there was missing data.  Missing data specifically impacted 
transfusions, race, and ethnicity variables.  BCH was not the birth hospital, rather infants 
were transferred to BCH for management of other conditions such as NEC, PDA, and 
extreme prematurity. Therefore, the population treated at BCH is not generalizable to the 
total population of premature infants. This is a sample at a Level IV center, so results 
may only be generalized to other preterm patients cared for at Level IV NICUs.  
Future research 
This research revealed several opportunities for future research. Measurement of 
EUGR was based the Fenton Growth Chart the most consistent measure in the literature 
(Fenton & Kim, 2013). However, there may be a superior method such as examining not 
only the weight on a growth chart at a single point, but rather pattern of weight gain or 
loss. Perhaps using the definition of FTT (weight decline of ≥ 2 major percentiles on the 
growth chart at separate points of assessment) would be more meaningful (Cole & 
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Lanham, 2011).  Examining MVU more comprehensively, such as patterns of placental 
blood flow and maternal hypertension would be more comprehensive to fully assess 
MVU.  Finally, testing an updated risk assessment tool that includes the additional 
variables from this research may lead to more comprehensive diagnosis of each grade of 
BPD. 
Professional Practice Implications 
The purpose of this research was to examine the risk factors for BPD as identified 
in the developed mid-range theory (see Figure 1). With such significant health, economic, 
and societal costs, identifying infants at risk and targeting interventions to reduce BPD 
are critical (Abman et al., 2017; Laughon et al., 2011). The normal line of defense 
represents the usual health state of the client (Fawcett & Neuman, 2011).  Findings from 
this research can be used to implement surveillance and/or preventative management for 
BPD, thus establishing the Normal Line of Defense for these fragile infants.   
The most recent and applicable BPD risk assessment tool includes gestational age, 
birth weight, sex, race/ethnicity, postnatal day (maximum of 28 days), ventilator type, 
and oxygen requirement (Laughon et al., 2011).  These risk assessment variables were 
validated through this research however the addition of number of surfactant 
administrations, diagnosis of NEC, number of postnatal infections, and presence of PDA 
may help to more accurately predict the development and severity of BPD.   
The Normal Line of Defense 
Improving the survival and health of infants has been a national focus since 1963, 
Despite improvements in preterm infant survivability, BPD continues to be a formidable 
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threat. Identification of infants through a BPD risk assessment is critical so risk reduction 
efforts can be implemented thus improving the health of preterm survivors.  
This research demonstrated the need to add several variables to the current risk 
assessment tool including surfactant administration, a diagnosis of NEC, postnatal 
infections, and PDA. Further, understanding the stressors and identifying infants at risk 
may lead to risk reduction and treatment strategies that can be targeted to prevent BPD. 
Risk reduction strategies such as early postnatal steroid administration (Clauss et al., 
2020) could be implemented for infants that require more than one dose of surfactant and 
those with postnatal infection(s).  Further, the role of PDA and incorporating early 
systematic surveillance to the care for preterm infants requires examination. 
Opportunities exist to intervene earlier if damage from over circulation into the lungs can 
be diagnosed prior to the onset of significant injury. These risk reductions strategies 
described, provide just a couple examples of the treatment strategies for BPD prevention. 
With innovation and research perhaps these strategies will be replaced with more 












Table 1 Criteria for Diagnosis of Bronchopulmonary Dysplasia 
Table 1 
Criteria for diagnosis of bronchopulmonary dysplasia (BPD) 
 





as any O2 
requirement at 28 
days of life for 
infants born <32 
weeks gestation. It 
is diagnosed at 36 
weeks corrected 





least 28 days, in 
room air at 36 

















least 28 days 
and < 30% O2 
at 36 weeks or 
discharge* 
Severe (type 1): 
O2 treatment at 
least 28 days 
and on ≥30% 
O2 or nasal 
CPAP/HFNC at 
≥ 36 weeks 
CGA 
Severe (type 2): 
O2 treatment at 
least 28 days 
and on 
mechanical 
ventilation at ≥ 
36 weeks CGA 
Abman et al., 2017  
Note: 23.1% of infants born <32 weeks’ gestation have no BPD 
CPAP (continuous positive airway pressure) and HFNC (high flow nasal cannula) 





Table 2 Operational Definitions 
Table 2 
Operational Definitions 
Extrauterine growth restriction 
(EUGR) 
Weight less than 10th percentile for age 
Necrotizing enterocolitis A disorder of ischemic necrosis of the 
intestine, predominantly found in very 
preterm infants. 
Stage 1: signs of sepsis, feeding intolerance, 
abdominal distention, occult blood in the 
stool 
Stage 2: signs from Stage 1 plus abdominal 
radiographs demonstrating rigid bowel loops, 
pneumatosis, portal venous gas 
Stage 3: signs from Stage 1 and 2 plus signs 
of shock and abdominal radiographic 
evidence of bowel perforation 
Neurodevelopmental impairment Represents a wide variety of manifestations 
such as cerebral palsy, cognitive delay, and 
more. 
Patent ductus arteriosus (PDA)  A ductus arteriosus is a vascular connection 
shunting blood from the lungs to the systemic 
vascular system in the fetus. A PDA occurs 
when this fails to close postnatally. 
Postmenstrual age (PMA) Gestational age plus time elapsed at birth 
Pulmonary hypertension Elevated pulmonary pressure and manifesting 
with hypoxia. Can develop among infants 
with BPD. Associated with more complex 
hospitalizations, higher costs, and increased 
risk for morbidity. 
Respiratory distress syndrome (RDS) A syndrome found in preterm infants related 
to surfactant deficiency, leading to increased 
work of breathing and varying respiratory 
support requirements. 
Surfactant A soapy substance that reduces surface 
tension in the lungs. It is deficient in preterm 
infants due to lung immaturity, leading to 
Respiratory Distress syndrome. 





















Black mothers are more likely to experience 
preterm births (CDC, 2016), but the role of 
race/ethnicity and the development of BPD is 
conflicting.  
 Sex Male infants have an increased risk for developing 




Inflammation Prenatal inflammation is evidenced by 
inflammatory changes in the placenta (Redline, 
2006). Chorioamnionitis is a maternal infection 
that causes inflammatory changes in the placenta 
(Kim et al., 2008; Ogihara et al., 2006; Rocha et 
al., 2012). 
Infection Chorioamnionitis is a prenatal infectious process 
that increases risk for BPD (Arayici et al., 2014; 
Ballard et al., 2016; Kibel et al., 2016; Lee et al., 




Maternal hypertensive disorders cause maternal 
vascular underperfusion and increase the risk for 
BPD and BPD associated pulmonary hypertension 
(Mestan et al., 2014; Mestan et al., 2017; Solimon 
et al., 2017; Torchin et al., 2016).  
Fetal growth restriction is defined as fetal growth 
at < 10th percentile for gestational age, fetal 
growth restriction is associated with maternal 
vascular underperfusion.  It is defined using birth 
weight, and it is related to the development of 






There is an increased risk for development of BPD 
as gestational age decreases (Binet et al., 2012; 
Dravet-Gounot et al., 2018; Mestan et al., 2014; 
Torchin et al., 2016; Tsai et al., 2015).  
Lower birth weights are associated with BPD 
development (Dravet-Guonot et al., 2018; Guo et 
al., 2015).  
Inflammation Mechanical ventilation and oxygen exposure 
contribute to inflammatory changes and increase 
the risk for BPD (Inatomi et al., 2012; Klevebro et 
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al., 2019; Mailaparambil et al., 2010; Oh et al., 
2005; Ohlin et al., 2015; Ozkan et al., 2012; 
Rutkowska et al., 2019; Yum et al., 2018).  
Necrotizing enterocolitis is an inflammatory 
bowel infection and is associated with BPD 
development (Janevic et al., 2018; Ozkan et al., 
2012).  
Infection Postnatal infections are represented by positive 
bacterial cultures from blood, spinal fluid, tracheal 
aspirates, and/or urine (Ballard et al., 2016; 
Dravet-Gounot et al., 2018; Durrmeyer et al., 
2012; Guo et al., 2015; Klevebro et al., 2019; Lee 
et al., 2011; Ohlin et al., 2015; Solimon et al., 
2017; Torchin et al., 2016). A diagnosis of 
necrotizing enterocolitis will also be considered 
an infection (Bell et al., 1978).  
Doses of 
surfactant 
Higher doses of surfactant is associated with a 
risk for BPD development ((Dravet-Gounot et 
al., 2018; Guo et al., 2015; Hofer et al., 2013; 
Torchin et al., 2016). 
 
Transfusions 
of packed red 
blood cells 
Higher volume of packed red blood cell 
transfusions is associated with an increased risk 




Presence of a PDA, and whether medical or 
surgical closure is required, is associated with an 
increased risk for BPD (Dravet-Gounot et al., 
2018; Demirel et al., 2009; Guo et al., 2015; 




Postnatal growth measured at < 10th percentile for 
gestational age is associated with development of 











Table 4 Data Abstraction Tool 
Table 4 
 





Ethnicity Hispanic Yes 
No 
Unknown 













restriction (< 10th 
percentile for age 




















Gestational age Completed 
weeks  
 
















Number of days 
 






starting in 2010 and 
minutes in 2016) 
 
admitted prior to 
key date) look at 
support on that 
date, and that 
gives diagnosis) 
If < 32 weeks 
and admitted 
after key date, 
they need to be 
on respiratory 
support for > 28 
days and if they 
meet that 
criteria, the days 
of ventilation are 
counted.  
 
Cut off at 36 



























enterocolitis ≥ Bell’s 







If Yes NEC Medical NEC 
 Surgical NEC: 
Drain placement or 
Open abdomen 
Recurrent NEC 























Diagnosis of BPD 
Select Yes 
No 
Grading (select) None 
Mild 
Moderate 
Severe Type 1 
Severe Type 2 



















Table 5 Inclusion and Exclusion Criteria 
Table 5 
 
Inclusion and Exclusion Criteria 
 
Inclusion Exclusion 
Birth at < 32 weeks’ gestation Major congenital anomalies (excluding 
PDA) 
Congenital renal disease 
Outcome of BPD cannot be determined 
























Figure 2 PRISMA Diagram 
 


























Records identified in the CHND 
for potential inclusion 




























(n = 645) 
Records excluded (n =190) 
Major congenital anomaly (n= 122) 
Outcome of BPD cannot be determined (n=54) 
Congenital renal disease (n=11) 
Neuromuscular disorders (n=2) 
Metabolic disorders (n=1) 
 
Records included 
(n = 455) 
76 
 
Table 6 Description of the Sample 
Table 6 
 
Description of the Sample 
 
Variable Frequency (n) Percentage (%) 
Sex 
Male 284 62.4 
Female 171 37.6 
Ethnicity 
Hispanic or Latino 48 10.5 
Not Hispanic or Latino 274 60.2 
Unknown 133 29.2 
Race 
White 218 47.9 
Black/African American 78 17.1 
Asian 18 4 
Native American/Alaskan 1 0.2 
Native Hawaiian/Pacific Islander 0 0 
Other 49 10.8 
Unknown 96 21.1 
Fetal growth restriction 
Yes 81 17.8 
No 369 81.1 
Missing 5 1.1 
Chorioamnionitis 
Yes 57 12.5 
No 394 86.6 
Missing 4 0.9 
Maternal vascular underperfusion 
Yes 116 25.5 
No 336 73.8 
Missing 3 0.7 
   
Variable Median Interquartile Range 
Gestational age (completed weeks) 26 25, 28 
Birth weight (grams) 820 650, 1090 
Mechanical ventilation 
Non-invasive mechanical ventilation 
(days) 
25 10, 44 
Invasive mechanical ventilation (days) 32 8, 61 









Number of infections Frequency (n) Percent (%) 
Pneumonia 
0 341 74.9 
1 73 16 
2 33 7.3 
3 5 1.1 
6 1 0.2 
Missing 2 0.4 
Blood stream infection 
0 332 73 
1 99 21.7 
2 19 4.2 
3 3 0.7 
Missing 2 0.4 
Meningitis 
0 427 93.8 
1 25 5.5 
2 1 0.2 
Missing 2 0.4 
Urinary tract infections 
0 395 86.8 
1 47 10.3 
2 11 2.4 
Missing 2 0.4 
Total infections 
0 224 49.2 
1 119 26.2 
2 66 14.5 
3 30 6.6 
4 13 2.9 
9 1 0.2 







Table 8 PDA and NEC Diagnoses 
Table 8 
 
PDA and NEC Diagnoses 
 
Variable Frequency (n) Percentage (%) 
PDA diagnosis 
Yes 284 62.4 
No 169 37.1 
Unknown 2 0.4 
PDA medical treatment 
Yes 194 42.6 
No 261 57.4 
PDA surgical treatment 
Yes 101 22.2 
No 354 77.8 
PDA medical and surgical treatment 
Yes 65 14.3 
No 390 85.7 
NEC diagnosis 
Yes 151 33.2 
No 303 66.6 
Unknown 1 0.2 
NEC medical treatment 
Yes 72 15.8 
No 383 84.2 
NEC surgical treatment 
Yes 99 21.8 
No 356 78.2 
NEC medical and surgical treatment 
Yes 20 4.4 



















Group No Yes Total 
Group 1 
0 (78) 
45 33 78 
Group 2 
1-2 (74) 
16 58 74 
Group 3 
3-6 (86) 
6 80 86 
Group 4 
7 and > (76) 
1 75 76 




Table 10 BPD Diagnosis and Grading 
Table 10 
 
BPD Diagnosis and Grading 
 
Variable Frequency (n) Percentage (%) 
BPD diagnosis 
Yes 381 83.7 
No 73 16.3 
Grade 
Mild 70 15.4 
Moderate 54 11.9 
Severe (type 1) 168 36.9 








Table 11 Bivariate Analysis of the Extrapersonal Stressors and BPD  
Table 11 
 
Bivariate Analysis of the Extrapersonal Stressors and BPD 
 
 BPD Diagnosis   
 Yes No   
Variable n (%) n (%) X2(df) p value 
Race 
White 172 (78.9) 46 (21.1) 7.19 (1) <0.01 
Asian 14 (77.8) 4 (22.2) 0.49 (1) 0.49 
Black/African American 68 (87.2) 10 (12.8) 0.82 (1) 0.37 
Other 47 (10.3) 2 (0.4) 5.98 (1) 0.01 
Unknown 84 (87.5) 12 (12.5) 1.27 (1) 0.26 
Native Alaskan 1 (100) 0 (0) 0.2 (1) 0.66 
Ethnicity 5.79 (2) 0.06 
Hispanic/Latino 46 (95.8) 2 (4.2)   
Not Hispanic/Latino 225 (82.1) 49 (17.9)   
Unknown 110 (82.7) 23 (17.3)   
Sex 1.21 (1) 0.27 
Female 139 (81.3) 32 (18.7)   
Male 242 (85.2) 42 (14.8)   
There were zero Native Hawaiian/Pacific Islander 
Row percentage was reported here.  

















Bivariate Analysis of the Interpersonal Stressors and BPD 
 
 BPD Diagnosis   
 Yes No   
Variable n (%) n (%) X2(df) p value 
Chorioamnionitis 51 6 1.76 (2) 0.42 
Maternal vascular 
underperfusion 
100 16 0.53 (2) 0.53 






















Table 13 Bivariate Analysis of the Intrapersonal Stressors and BPD 
Table 13 
 
Bivariate Analysis of the Intrapersonal Stressors and BPD 
 
Continuous Variables 
Variable Median IQR SD Z p value 
Gestational age (weeks) 26 25, 28 2.93 -18.52 <0.01 
Birth weight (grams) 820 650, 
1090 
348.38 -18.4 <0.01 
Non-invasive MV (days) 25 10, 44 23.37 -17.37 <0.01 
Invasive MV (days) 32 8, 60.8 44.34 -16.62 <0.01 
Total days MV (days) 63 29, 91 46.85 -18.22 <0.01 
Total infections 1 0, 1 1.14 -13.7 <0.01 
 Median IQR SE U p value 
Surfactant 1 1, 2 931.74 7.2 <0.01 
Categorical Variables 
 BPD Diagnosis   
 Yes No   
Variable n (%) n (%) X2(df) p value 
Transfusions 89.16 <0.01 
0 transfusions 33 45   
1-2 transfusions 58 16   
3-6 transfusions 80 6   
≥ 7 transfusions 75 1   
NEC categories 21.73 <0.01 
No NEC 240 63   
Medical NEC 46 6   
Surgical NEC 75 4   
Medical and Surgical NEC 20 0   
PDA categories 60.41 <0.01 
No PDA 45 9   
PDA, no treatment 115 56   
Medically treated PDA 122 7   
Surgically treated PDA 35 1   
Medically and surgically treated PDA 64 1   
Extrauterine growth restriction 228 24 20.2 <0.01 
 U is standardized test statistic 











 1 2 3 4 5 6 7 8 9 10 11 12 13 
GA 1             
BW .76 
** 






































































































































































**Correlation is significant at the 0.01 level (2-tailed) 




























Table 15 Binary Logistic Regression Analysis of the Predictive Variables and BPD 
Table 15 
 
Binary Logistic Regression Analysis of the Predictive Variables and BPD 
 
 Univariate Logistic Regression Multivariate Logistic Regression 
Independent 
Variables 
OR (95% CI) P value OR (95% CI) P value 
Gestational 
age (weeks) 
0.39 (0.32, 0.48) <0.01 1.29 (0.741, 2.25) 0.37 
Birth weight 
(GA) 
0.99 (0.99, 0.99) <0.01 0.99 (0.99, 1) 0.04 
FGR 3.4 (1.34, 8.81) 0.01 0.59 (0.07, 5.09) 0.64 
Doses of 
surfactant 
3.86 (2.57, 5.79) <0.01 2.49 (1.07, 5.77) 0.03 
Total days of 
mechanical 
ventilation 
1.18 (1.13, 1.23) <0.01 1.19 (1.11, 1.27) <0.01 
Total 
infections 
2.31 (1.59, 3.37) <0.01 0.45 (0.19, 1.03) 0.06 
EUGR 3.21 (1.89, 5.44) <0.01 0.89 (0.24, 3.29) 0.87 
Transfusion 
groups 
1.8 (1.47, 2.19) <0.01 0.89 (0.67, 1.18) 0.43 
Race: 
population 
1.16 (1.04, 1.29) 0.01 8979712 (0.00) 0.99 
PDA 
(categorical) 
7.2 (4,05, 12.78) <0.01 1.55 (0.37, 6.45) 0.55 
PDA 
(interval) 
5.71 (2.99, 10.88) <0.01 2.57 (0.84, 7.86) 0.09 
NEC 
(categorical) 
3.37 (1.72, 6.6) <0.01 2.1 (0.27, 16.08) 0.48 
NEC 
(interval) 
1.77 (1.27, 2.74) <0.01 1.66 (0.75, 3.7) 0.22 
 








Table 16 Bivariate Analysis of Extrapersonal Stressors by BPD Grade 
Table 16 
 
Bivariate Analysis of Extrapersonal Stressors by BPD Grade 
 
 BPD Grade  



































4.6 (4) 0.33 
Asian 4 (5.5) 0 (0) 0 (0) 14 
(8.3) 
0 (0) 17.73 
(4) 
<0.01 









27 (30) 6.58 (4) 0.16 
Ethnicity 9.54 (8) 0.29 
Hispanic or 
Latino 

































































Table 17 Bivariate Analysis of Interpersonal Stressors by BPD Grade 
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Bivariate Analysis of Interpersonal Stressors by BPD Grade 
 
 BPD Grade 






   
Variable n (%) n 
(%) 








































Bivariate Analysis of Intrapersonal Stressors and BPD Grade 
 
Variable Median IQR SD Z p value 
Gestational age 
(weeks) 
26 25, 28 2.39 -18.51 <0.01 
Birth  820 650, 
1090 
348.38 -18.4 <0.01 
Total MV (days) 63 29 91 -18.22 <0.01 
Total infections 1 0, 1 1.14 -17.72 <0.01 
 BPD Grading    




   





0 doses 35 17 5 17 6    
1 dose 31 33 33 71 36    
2 doses 3 16 12 63 32    
3 doses 2 2 3 11 10    
4 doses 0 0 0 3 3    
Transfusion groups 185.22 
(16) 
0.64 <0.01 
0 transfusions 45 15 8 9 1    
1-2 transfusions 16 13 14 27 4    
3-6 transfusions 6 14 13 40 13    
≥ 7 transfusions 1 7 8 30 30    
NEC categories 39.25 
(16) 
0.29 <0.01 
No NEC 62 39 43 106 53    
Medical NEC 6 6 6 25 9    
Surgical NEC 4 20 4 30 21    
Medical and 
Surgical NEC 
0 5 1 7 7    
PDA categories 89.34 
(16) 
0.44 <0.01 
No PDA 8 9 9 19 9    
PDA, no 
treatment 





7 14 19 56 33    
Surgically treated 
PDA 




1 5 9 32 18    



























Table 19 Multinomial Regression Analysis of Predictive Variables and Mild BPD 
Table 19 
 
Multinomial Regression Analysis of Predictive Variables and Mild BPD 
 




Independent Variables OR (95% CI) p value OR (95% CI) p value 
Race: White 1.12 (0.55, 2.28) 0.75 0.75 (0.23, 2.46) 0.64 
Race: Other 0.16 (0.03, 0.8) 0.03 0.31 (0.03, 3.52) 0.35 
FGR 0.96 (0.26, 3.46) 0.94 2.22 (0.22, 22) 0.5 
Gestational age 0.45 (0.36, 0.56) <0.01 1.08 (0.61, 1.89) 0.79 
Birth weight 0.99 (0.99, 0.99) <0.01 0.99 (0.99, 1) 0.13 
Doses of surfactant 2.47 (1.5, 4.04) <0.01 1.89 (0.83, 4.34) 0.13 
Total days of 
mechanical ventilation 
1.16 (1.11, 1.21) <0.01 1.16 (1.1,1.22) <0.01 
Total infections 1.51 (0.93, 2.44) 0.1 0.36 (0.14, 0.9) 0.03 
Transfusion (0) 0.19 (0.06, 0.66) <0.01 1.06 (0.13, 8.92) 0.96 
Transfusions (1-2) 0.19 (0.06, 0.66) <0.01 1.46 (0.2, 10.72) 0.71 
Transfusions (3-6) 0.56 (0.14, 2.22) 0.4 2.29 (0.22, 24.35) 0.49 
Transfusions (>7) 1.67 (0.17, 
16.81) 
0.67 2.03 (0.05, 84.54) 0.49 
PDA (interval) 3.27 (1.61, 6.65) <0.01 2.06 (0.77, 5.56) 0.15 
PDA (categorical) 0.36 (0.18, 0.74) <0.01 0.64 (0.18, 2.3) 0.49 
NEC (interval) 2.06 (1.44, 2.95) <0.01 2.17 (1.09, 4.35) 0.03 
NEC (categorical) 0.22 (0.1, 0.49) 0.22 0.28 (0.05, 1.44) 0.13 
EUGR 0.55 (0.28, 1.08) 0.08 1.79 (0.44, 7.32) 0.41 
 
 
For entire model: X2 629.59 (df 84), p<0.01. Goodness-of-Fit X2 1715.85 (PDA and NEC 
categorical) 














Multinomial Regression Analysis of Predictive Variables and Moderate BPD 
 






OR (95% CI) p value OR (95% CI) p value 
Race: White 0.98 (0.45, 2.11) 0.95 0.86 (0.24, 3.04) 0.82 
Race: Other 0.14 (0.03, 0.72) 0.02 0.23 (0.02, 2.95) 0.26 
FGR 0.92 (0.24, 3.65) 0.92 2.44 (0.22, 26.88) 0.47 
Gestational age 0.4 (0.32, 0.51) <0.01 1.05 (0.57, 1.93) 0.87 
Birth weight 0.99 (0.99, 0.99) <0.01 0.99 (0.99, 1) 0.11 
Doses of surfactant 3.45 (2.05, 5.8) <0.01 2.48 (1.04, 5.89) 0.04 
Total days of MV 1.17 (1.12, 1.22) <0.01 1.15 (1.09, 1.22) <0.01 
Total infections 1.44 (0.86, 2.39) 0.17 0.36 (0.14, 0.94) 0.04 
Transfusion (0) 0.08 (0.02, 0.3) 0.67 1.44 (0.15, 14) 0.75 
Transfusion (1-2) 0.4 (0.11, 1.43) 0.16 2.84 (0.35, 23.43) 0.33 
Transfusion (3-6) 0.99 (0.24, 4.13) 0.98 3.28 (0.29, 36.39) 0.33 
Transfusion (>7) 3.64 (0.35, 
37.46) 
0.28 4.1 (0.09, 188.17) 0.47 
PDA (categorical) 0.01 (0.04, 0.22) <0.01 0.16 (0.04, 5.9) 0.01 
PDA (interval) 5.91 (2.96, 
11.81) 
<0.01 3.35 (1.27, 8.84) 0.02 
NEC (categorical) 0.69 (0.28, 1.74) 0.44 1.2 (0.21, 6.9) 0.84 
NEC (interval) 1.22 (0.79, 1.89) 0.37 0.92 (0.42, 2.02) 0.84 















Multinomial Regression Analysis of Predictive Variables and Severe (Type 1) BPD  
 




Variable OR (95% CI) P value OR (95% CI) P value 
Race: White 1.67 (0.94, 
2.98) 
0.08 1.27 (0.36, 4.47) 0.71 
Race: Other 0.31 (0.07, 
1.42) 
0.13 0.9 (0.07, 11.49) 0.94 
FGR 0.24 (0.9, 
0.63) 
<0.01 1.02 (0.1, 10.28) 0.98 
Gestational age 0.38 (0.31, 
0.47) 
<0.01 2.07 (1.13, 3.79) 0.02 
Birth weight 0.99 (0.99, 
0.99) 
<0.01 0.99 (0.99, 0.99) 0.01 
Doses of surfactant 4.79 (3.05, 
7.51) 
<0.01 2.61 (1.09, 6.23) 0.03 
Total days of MV 1.22 (1.17, 
1.28) 
<0.01 1.23 (1.16, 1.31) <0.01 
Total infections 2.44 (1.62, 
3.68) 
<0.01 0.44 (0.17, 1.11) 0.08 
Transfusion (0) 0.02 (0.01, 
0.05) 
<0.01 0.42 (0.04, 4.14) 0.45 
Transfusion (1-2) 0.14 (0.05, 
0.41) 
<0.01 0.88 (0.11, 7.21) 0.91 
Transfusion (3-6) 0.54 (0.15, 
1.88) 
0.33 1.34 (0.13, 14.39) 0.81 
Transfusion (>7) 2.42 (0.27, 
21.64) 
0.43 1.34 (0.03, 59.75) 0.88 
PDA (categorical) 0.01 (0.05, 
0.19) 
<0.01 0.19 (0.05, 0.73) 0.02 
PDA (interval) 6.44 (3.33, 
12.47) 
<0.01 3.77 (1.39, 10.2) <0.01 
NEC (categorical) 0.3 (0.15, 
0.62) 
<0.01 0.49 (0.09, 2.76) 0.42 
NEC (interval) 1.67 (1.18, 
2.38) 
<0.01 1.51 (0.72, 3.16) 0.28 
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EUGR 0.27 (10.15, 
0.49) 

































Multinomial Regression Analysis of Predictive Variables and Severe (Type 2) BPD 
 




Variable OR (95% CI) p value OR (95% CI) p value 
Race: White 2.66 (1.38, 
5.11) 
<0.01 1.85 (0.46, 7.52) 0.39 
Race: Other 0.41 (0.08, 
2.04) 
0.28 1.13 (0.08, 16.58) 0.93 
FGR 0.17 (0.06, 
0.47) 
<0.01 0.6 (0.05, 7.27) 0.69 
Gestational age 0.35 (0.28, 
0.44) 
<0.01 2.34 (1.21, 4.5) 0.01 
Birth weight 0.99 (0.99, 
0.99) 
<0.01 0.99 (0.99, 1) 0.06 
Doses of surfactant 5.98 (3.67, 
9.73) 
<0.01 3.07 (1.21, 7.79) 0.02 




<0.01 1.27 (1.19, 1.35) <0.01 
Total infections 4.22 (2.72, 
6.52) 
<0.01 0.55 (0.21, 1.46) 0.23 
Transfusion (0) 0.00 (0.00, 
0.02) 
<0.01 0.32 (0.01, 7.05) 0.47 
Transfusion (1-2) 0.03 (0.01, 
0.13) 
<0.01 0.45 (0.04, 5.02) 0.51 
Transfusion (3-6) 0.26 (0.07, 
0.99) 
0.05 0.97 (0.08, 11.83) 0.98 
Transfusion (>7) 2.42 (0.27, 
21.64) 
0.43 2.3 (0.05, 107.95) 0.67 
PDA (categorical) 0.1 (0.05, 
0.21) 
<0.01 0.16 (0.04, 0.7) 0.02 
PDA (interval) 6.55 (3.35, 
12,84) 
<0.01 4.75 (1.69, 13.34) <0.01 
NEC (categorical) 0.25 (0.12, 
0.55) 
<0.01 0.49 (0.08, 3.12) 0.46 
NEC (interval) 1.95 (1.37, 
2.78) 
<0.01 1.84 (0.85, 3.9) 0.12 
EUGR 0.25 (0.13, 
0.47) 
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